| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
ResMed Inc.$203.87
-4.65 (-2.23%)
C 53Pipeline Score MedTech · Commercial
Market Cap
30.18 B
EPS
10.41
P/E Ratio
20.06 $
Value Trade
314.36 M
SEC Financials
Q1 2026Dilution Risk
Revenue
1.43 B
R&D Expenses
94.27 M
Total Assets
8.78 B
Total Liabilities
2.29 B
Equity
6.49 B
D/E Ratio
12,345
1.98 %
Week
-6.28 %
1 Month
-18.62 %
3 Month
-14.83 %
6 Month
2.99 %
5 Year
27,640 %
All Time
Cash Data
Cash Position
1.66 B
Monthly Burn
-
Runway
12,345 mo
Burn Trend
StableSEC Filing
May 1, 2026
Overview
Volume
1.33 M
52 Week Range
198.61 - 293.81
% held by Insiders
0.93 %
% held by Institutions
76.02 %
Enterprise Value
29.36 B
Total Shares
145.65 M
Short %
8.99 %
Float Shares
144.48 M
Company Description
locked
Upcoming Catalyst
Catalyst Timeline
Dated clinical, regulatory & corporate events for ResMed Inc.
173Total events
3Upcoming
23Tier-1 (high impact)
2018 – 2029Coverage
Upcoming catalysts 3
Event history 170
Jul 7, 2026
◆AcquisitionCorporate
ResMed enters definitive agreement to sell MatrixCare business to Frazier Healthcare Partners
Jun 2, 2026
◆Oral PresentationPresentation
ResMed to present at 46th Annual William Blair Growth Stock Conference
Jun 1, 2026
Apr 30, 2026
Apr 30, 2026
▲Product LaunchPost-Market
Launched AirTouch F30i Comfort full face mask in the U.S.
Sleep apneasource ↗
Jan 12, 2026
◆Oral PresentationPresentation
ResMed presentation at 44th Annual J.P. Morgan Healthcare Conference
Jan 2026
▲Product LaunchPost-Market
Limited U.S. beta launch for new myAir users
obstructive sleep apneasource ↗
2026
◆Quarterly UpdateCorporate
ResMed to provide financial impact update in Q4 FY2026 regulatory filings
Drug Pipeline Intelligence
C53
Pipeline Score $2.8B
Pipeline ValueValuation Signal
1
Drugs Scored0.3x
rNPV / MCap Top 80%
Mid Cap (rank 183 of 911)
Percentile RankResMed Inc. carries a moderate pipeline score (53/100), with $3.3B risk-adjusted pipeline value, led by Eszopiclone in Sleep Apnea (Phase 3).
Showing 1 of 1 assets
| Drug | Indication | Phase | NCT ID | PTRS | rNPV | Status | Enrollment | Velocity | Design | Completion | ML Signal | Last Change |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eszopiclone Small molecule | Sleep Apnea | Phase 3 | NCT07332442 | 55% | $3.3B | RECRUITING | 250 | - | - | Jun 1, 2030 | - | May 21, 2026 |
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in RMD
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
RMD Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-07-17 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-07-17 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-07-17 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
RMD▼ -6.3%on this news
Resmed Announces Agreement to Sell MatrixCare Business
Resmed has announced a definitive agreement to sell its MatrixCare business to Frazier Healthcare Partners. This decision aligns with Resmed's 2030 strategy to concentrate on scalable opportunities in sleep and breathing health. The transaction is expected to close in the first quarter of fiscal year 2027, pending regulatory approvals. Resmed aims to enhance its focus on innovation and operational scale.
Read more →RMDResmed to Report Fourth Quarter Fiscal 2026 Earnings on August 6, 2026
Resmed has announced that it will release its financial results for the fourth quarter of fiscal year 2026 on August 6, 2026. Following the release, management will host a webcast to discuss the results and other material information. The webcast will be accessible via their investor relations website.
Read more →RMDObstructive Sleep Apnea in Women: What You Need to Know
The article discusses the rising prevalence of obstructive sleep apnea (OSA) among women, highlighting that it is often underdiagnosed due to differing symptoms compared to men. Factors such as hormonal changes during pregnancy and menopause contribute to increased risk. Effective treatments, including CPAP therapy and lifestyle modifications, are available to manage symptoms. The importance of early diagnosis and awareness is emphasized to improve women's health outcomes.
Read more →RMDYour sleep therapy support app: New myAir features designed around you
The myAir app has introduced new features aimed at improving sleep therapy experiences. Key updates include Smart Comfort for personalized settings, a digital sleep coach named Dawn for ongoing support, and a Streaks feature to track therapy consistency. These enhancements are designed to empower users in their sleep therapy journey.
Read more →RMDTrain Your Airway: How Myofunctional Therapy Helps Sleep Apnea
Myofunctional therapy offers a promising approach to managing obstructive sleep apnea (OSA) by strengthening the muscles around the upper airways. This therapy can complement traditional treatments such as CPAP, potentially improving their effectiveness. Regular practice of specific exercises may lead to reduced symptoms, including snoring and daytime sleepiness. Consistency in performing these exercises is crucial for optimal results.
Read more →RMDThe Tongue and Sleep Apnea: What You Need to Know
The article discusses the role of the tongue in obstructive sleep apnea (OSA), highlighting how its size and position can block the airway during sleep. It outlines various treatment options, including CPAP therapy, oral appliances, and tongue exercises. The importance of consulting a doctor for diagnosis and personalized treatment is emphasized, along with emerging research in the field.
Read more →RMDNasal Strips, Sprays, and Devices: Do They Help with Sleep Apnea?
Nasal aids such as strips, sprays, and devices can help improve airflow and comfort for individuals with sleep apnea, particularly those using CPAP therapy. However, these aids are not a standalone treatment for sleep apnea and may only alleviate symptoms like snoring. EPAP devices may offer some benefits for mild cases, but overall, continuous positive airway pressure (CPAP) remains the most effective treatment.
Read more →RMDTypes of Sleep Apnea: Obstructive and Central
The article discusses the two main types of sleep apnea: obstructive sleep apnea (OSA) and central sleep apnea (CSA). OSA is the most prevalent type, affecting nearly 1 billion people globally, while CSA is less common and often linked to underlying medical conditions. Understanding these types is crucial for effective diagnosis and treatment, which can significantly improve quality of life.
Read more →RMDResmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio
Resmed has completed its acquisition of Noctrix Health, enhancing its clinical sleep health offerings. This acquisition includes the Nidra® Tonic Motor Activation (TOMAC) Therapy, a non-invasive treatment for moderate-to-severe Restless Legs Syndrome (RLS). The integration of Noctrix's technology aims to improve patient access and outcomes in sleep health. Resmed's CEO expressed optimism about scaling solutions to enhance lives through better sleep.
Read more →RMDResmed and ŌURA Partner to Expand Access to Sleep Health Education and Care
Resmed has partnered with Oura to improve access to sleep health education and care. This collaboration aims to leverage wearable technology to help users better understand their sleep patterns and connect with healthcare resources. With a significant portion of sleep disorders going undiagnosed, the partnership seeks to raise awareness and facilitate informed discussions between users and healthcare providers.
Read more →RMDResmed Announces Participation in the 46th Annual William Blair Growth Stock Conference
Resmed has announced its participation in the 46th Annual William Blair Growth Stock Conference, scheduled for June 2, 2026. CEO Mick Farrell and CFO Aaron Bloomer will represent the company, with a webcast presentation set to begin at 4:40 p.m. Central Time. The event emphasizes Resmed's focus on innovative health technologies.
Read more →RMDHeadaches and Sleep: Could It Be Sleep Apnea?
The article discusses the link between sleep apnea and morning headaches, highlighting how low oxygen levels and sleep disruptions contribute to this issue. It emphasizes that CPAP therapy can alleviate headaches by ensuring proper airflow during sleep. Additionally, maintaining healthy habits is suggested to improve sleep quality and reduce headache occurrences.
Read more →RMDDeviated septum and sleep apnea: What you need to know
The article discusses the relationship between a deviated septum and obstructive sleep apnea (OSA). While a deviated septum is not typically the sole cause of OSA, it can exacerbate symptoms. Treatment options include surgery, such as septoplasty, and non-surgical methods. Ongoing monitoring and personalized treatment plans are essential for effective management.
Read more →RMDCPAP Masks for Sleep Apnea: Options, Benefits, and How to Choose
The article provides an overview of CPAP masks for sleep apnea, detailing the three main types: nasal, nasal pillow, and full-face masks. It emphasizes the importance of selecting the right mask based on individual needs, including sleep position and facial structure. Additionally, it highlights the significance of regular maintenance and professional fittings to optimize comfort and effectiveness.
Read more →RMDSleep Apnea and Heart Problems: A Comprehensive Overview
The article discusses the link between sleep apnea and heart health, emphasizing that untreated sleep apnea can strain the heart and increase the risk of conditions like high blood pressure and heart disease. It highlights the importance of diagnosis and treatment, including CPAP therapy, which can significantly lower cardiovascular risks. The article also notes the rising prevalence of obstructive sleep apnea, particularly among women, and the need for coordinated care among healthcare providers.
Read more →RMDResmed Chief Financial Officer Brett Sandercock to Retire; Aaron Bloomer Appointed as Successor
Resmed announced the retirement of CFO Brett Sandercock, effective May 4, 2026, after 27 years with the company. Aaron Bloomer, previously CFO at Exact Sciences, has been appointed as his successor. The leadership transition aims to support Resmed's 2030 strategy and continued growth in health technology. Sandercock will remain as an advisor until the end of 2027.
Read more →RMDResmed Inc. Announces Results for the Third Quarter of Fiscal Year 2026
Resmed Inc. reported strong financial results for Q3 FY 2026, with an 11% revenue increase to $1.4 billion. The company achieved significant gross margin expansion and a notable rise in earnings per share. CEO Mick Farrell highlighted the ongoing demand for their products and the strategic focus on enhancing digital health capabilities. Resmed also announced a new distribution center to bolster U.S. operations.
Read more →RMDFor Investors For Media Salli Schwartz Brad Lotterman Salli.Schwartz@resmed.com Brad.lotterman@resmed.com investorrelations@resmed.com news@resmed.com Resmed Chief Financial Officer Brett Sandercock to Retire; Aaron Bloo
Resmed announced the retirement of Chief Financial Officer Brett Sandercock, effective May 4, 2026, after 27 years at the company, including 20 as CFO. Aaron Bloomer, formerly CFO at Exact Sciences, has been appointed as Sandercock's successor. The transition is seen as positive, with expectations that Bloomer will effectively drive growth and support Resmed's vision for enhanced digital health solutions. Sandercock will continue to serve as an advisor through the end of 2027.
Read more →RMDFor investors For media +1 858-221-3304 +1 619-510-1281 investorrelations@resmed.com news@resmed.com Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2026 Revenue increased by 11% to $1.4 billion; up 8%
Resmed Inc. reported its third-quarter fiscal results for 2026, showcasing a strong performance with an 11% revenue increase year-over-year, amounting to $1.4 billion. The company also highlighted a significant 21% rise in earnings per share, supported by improved gross margins. CEO Mick Farrell emphasized the company's strategic focus on advancing sleep and breathing health through innovative technologies. Additionally, Resmed declared a quarterly cash dividend of $0.60 per share for its investors.
Read more →RMDSleep Apnea in Veterans: VA Claims, Disability Ratings, and Support
The article discusses the prevalence of sleep apnea among veterans, highlighting that they are more likely to develop the condition due to factors like PTSD and disrupted sleep during service. The U.S. Department of Veterans Affairs recognizes sleep apnea as a disability, offering support and resources for veterans to manage their condition. Effective treatments, particularly CPAP therapy, are available to improve veterans' sleep quality and overall health.
Read more →RMDHow CPAP Machines Help Treat Sleep Apnea
Continuous positive airway pressure (CPAP) therapy is highlighted as an effective treatment for obstructive sleep apnea (OSA), improving sleep quality and reducing health risks. The article discusses how CPAP works, its components, and the immediate and long-term benefits of consistent use. It also emphasizes the importance of personalized settings and comfort features in enhancing treatment success.
Read more →RMDWhat Does Your AHI Score Mean? Breaking Down Sleep Apnea Severity
The article explains the Apnea-Hypopnea Index (AHI), a crucial metric for assessing sleep apnea severity. An AHI score categorizes the condition from normal to severe based on the frequency of breathing interruptions during sleep. Treatment options, including CPAP therapy and lifestyle changes, are discussed, emphasizing the importance of personalized care based on AHI scores.
Read more →RMDSleep Apnea & High Blood Pressure: Understanding The Connection
The article discusses the intricate relationship between sleep apnea and high blood pressure, highlighting how each condition can exacerbate the other. It emphasizes the importance of treating sleep apnea, particularly with CPAP therapy, to potentially lower blood pressure and improve heart health. Additionally, it outlines lifestyle modifications and the significance of regular medical check-ups for effective management of both conditions.
Read more →RMDResmed to Report Third Quarter Fiscal 2026 Earnings on April 30, 2026
Resmed has announced the release date for its third quarter fiscal 2026 earnings, scheduled for April 30, 2026, after market close. Following the earnings report, management will host a webcast to discuss the results and other relevant information. The webcast will be accessible via a specific link, and replays will be available for a limited time.
Read more →RMDCan Surgery Fix Sleep Apnea? Exploring Your Options
The article discusses surgical options for treating obstructive sleep apnea (OSA), emphasizing that surgery is typically not the first treatment choice. It outlines various surgical techniques aimed at improving airflow by addressing specific airway blockages. While surgery can be beneficial for some patients, it is generally considered when other treatments, like CPAP therapy, have failed. The article also highlights the importance of consulting with a sleep specialist to evaluate the risks and benefits of surgery.
Read more →RMDMouth Guards for Sleep Apnea: Benefits and How They Work
Mouth guards, or oral appliances, are effective treatments for obstructive sleep apnea (OSA) by keeping the airway open during sleep. They come in two main types: mandibular advancement devices (MADs) and tongue retaining devices (TRDs). While CPAP is the most recognized treatment, mouth guards can be a viable alternative or used in conjunction with other therapies. Custom-fit devices prescribed by a doctor provide the best results.
Read more →RMDResmed’s Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach
Resmed's Global Sleep Survey reveals that while 53% of respondents consider sleep crucial for health, many struggle to achieve quality rest. The survey, conducted with 30,000 participants across 13 countries, highlights a gap between awareness and action, with only 23% seeking medical help for sleep issues. Increased use of wearables for sleep tracking indicates growing awareness, yet barriers remain in addressing sleep health effectively.
Read more →RMDCan You Die From Sleep Apnea?
The article discusses the serious health risks associated with untreated sleep apnea, particularly obstructive sleep apnea (OSA), which can lead to heart disease, stroke, and increased mortality. It highlights the importance of proper diagnosis and treatment, specifically Continuous Positive Airway Pressure (CPAP) therapy, which has been shown to improve health outcomes and potentially extend life expectancy. The article emphasizes the need for awareness and management of sleep apnea to mitigate its severe health impacts.
Read more →RMDResmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana
Resmed is set to open a new distribution center in Greenwood, Indiana, in 2027, enhancing its U.S. operations. This facility will serve as a logistics hub, improving delivery efficiency across North America and creating over 100 jobs. The center aims to strengthen Resmed's commitment to the local community while enhancing service to patients and providers.
Read more →RMDSnoring: What Causes It?
The article explores the causes, symptoms, and solutions for snoring, emphasizing its impact on sleep quality. While snoring can be harmless, it may also signal serious conditions like sleep apnea. Common causes include airway obstruction, relaxed throat muscles, and lifestyle factors. Effective solutions range from lifestyle changes to medical treatments.
Read more →RMDBest Sleep Positions For Sleep Apnea
The article discusses how sleep positions can influence sleep apnea symptoms, emphasizing that side or elevated sleeping positions are generally beneficial. It highlights the importance of positional therapy as a complementary approach to medical treatments like CPAP. The article also provides insights into various sleeping positions and their effects on airway blockage.
Read more →RMDResmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026
Resmed Inc. reported strong second quarter results for fiscal year 2026, showcasing an 11% increase in revenue and a significant expansion in gross margins. The company continues to experience robust demand for its sleep and respiratory care devices, alongside growth in its digital health ecosystem. Resmed plans to invest further in innovation to enhance global access to healthcare.
Read more →RMDFor investors For media +1 858-221-3304 +1 619-510-1281 investorrelations@resmed.com news@resmed.com Resmed Inc. Announces Results for the Second Quarter of Fiscal Year 2026 Revenue increased by 11% to $1.4 billion; up 9
Resmed Inc. reported strong financial results for the second quarter of fiscal year 2026, with revenue rising by 11% year-over-year to $1.4 billion. The company achieved significant gross margin expansion and continued its trend of mid-teens non-GAAP EPS growth, attributed to robust demand for its sleep and respiratory care devices. Resmed's CEO emphasized ongoing investments in innovation to enhance digital health capabilities and expand global access to care.
Read more →RMDCan Losing Weight Cure Sleep Apnea
The article discusses the relationship between sleep apnea and obesity, highlighting that losing weight can alleviate symptoms for some individuals. It emphasizes the importance of weight management as a complementary treatment for obstructive sleep apnea. However, it also notes that weight loss alone is not a cure, as other factors may contribute to the condition.
Read more →RMDObstructive Sleep Apnea
Obstructive sleep apnea (OSA) is a prevalent sleep disorder characterized by airway obstruction during sleep, leading to disrupted breathing. Symptoms include loud snoring, excessive daytime sleepiness, and morning headaches. Risk factors include obesity, age, and smoking. Diagnosis typically involves polysomnography or home sleep tests, and treatment options range from CPAP therapy to lifestyle changes.
Read more →RMD6 tips for a restful night
The article provides six actionable tips for improving sleep quality as the new year begins. It emphasizes the importance of establishing a personal wind-down routine, reserving the bed for sleep, and creating a calming bedroom environment. Additional advice includes limiting screen time before bed and incorporating daily physical activity. The article also introduces the '10-3-2-1-0' rule for better sleep habits.
Read more →RMDResmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026
Resmed has announced the release date for its second quarter fiscal 2026 earnings, scheduled for January 29, 2026. The financial results will be discussed in a webcast following the release. Resmed emphasizes its commitment to innovative health technologies that enhance patient care and well-being.
Read more →RMDSleep apnea testing and diagnosis
The article discusses the importance of diagnosing sleep apnea, highlighting symptoms such as fatigue and irritability. It explains the types of sleep apnea tests, including polysomnography and home sleep apnea tests, and emphasizes the need for early detection to prevent serious health complications. Treatment options range from lifestyle changes to CPAP therapy and surgery.
Read more →RMDSleep apnea signs and symptoms
The article discusses sleep apnea, a condition characterized by repeated breathing interruptions during sleep. Common symptoms include loud snoring, gasping for air, and excessive daytime sleepiness. If left untreated, sleep apnea can lead to severe health complications. The article emphasizes the importance of recognizing symptoms and consulting a healthcare professional for diagnosis and treatment.
Read more →RMDWhat is central sleep apnea?
Central sleep apnea (CSA) is a sleep disorder characterized by the brain's failure to signal breathing muscles during sleep. Unlike obstructive sleep apnea, CSA is linked to nervous system issues and underlying medical conditions. Symptoms include abnormal breathing patterns, shortness of breath, and insomnia. Effective treatments such as CPAP, ASV, and lifestyle changes can improve sleep quality and overall health.
Read more →RMDCan the right pillow help with sleep apnea?
The article discusses how specific types of pillows can assist individuals with sleep apnea by improving comfort and sleep posture. While pillows cannot cure sleep apnea, they can enhance the effectiveness of CPAP therapy and help reduce discomfort during sleep. Options like wedge, CPAP-compatible, and cervical pillows are highlighted for their supportive roles. Overall, a supportive pillow can be a valuable addition to a comprehensive treatment plan for sleep apnea.
Read more →RMDCan Apple Watch detect sleep apnea
The article discusses how the Apple Watch can assist in monitoring sleep health, particularly in detecting signs of sleep apnea. It highlights features such as heart rate variability, sleep stages, and breathing disturbances that can provide insights into sleep patterns. While the Apple Watch offers valuable data, it cannot diagnose sleep apnea and should be used as a preliminary tool before consulting a healthcare professional.
Read more →RMDSleep apnea: A comprehensive overview
The article provides a comprehensive overview of sleep apnea, a common condition affecting many adults. It details the types of sleep apnea, including obstructive, central, and complex sleep apnea syndrome. Symptoms and treatment options, such as CPAP therapy and lifestyle changes, are discussed, emphasizing the importance of diagnosis and management.
Read more →RMDResmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
Resmed (NYSE: RMD) has announced that its CEO Mick Farrell and CMO Dr. Carlos Nunez will present at the upcoming 44th Annual J.P. Morgan Healthcare Conference. The event is scheduled for January 12, 2026, in San Francisco. Resmed aims to showcase its advancements in life-changing health technologies and emphasizes its commitment to improving healthcare accessibility and effectiveness. Additional details and a live audio-only webcast will be available on their investor relations website.
Read more →RMDResmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy
Resmed has received FDA clearance for its Smart Comfort device, an AI-enabled tool designed to personalize CPAP therapy for patients with obstructive sleep apnea. Launching in early 2026, Smart Comfort will utilize machine-learning algorithms to recommend individualized comfort settings based on user data. This innovation aims to improve patient adherence and comfort during therapy.
Read more →RMDResmed Inc. Announces Results for the First Quarter of Fiscal Year 2026
Resmed Inc. reported strong first-quarter results for fiscal year 2026, achieving 9% revenue growth and 16% non-GAAP EPS growth compared to the previous year. The company's focus on home healthcare solutions and innovative technology underpins its success. A quarterly dividend of $0.60 per share was also declared, reflecting confidence in ongoing profitability.
Read more →RMDFor investors For media +1 858-221-3304 +1 619-510-1281 investorrelations@resmed.com news@resmed.com Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026 Revenue increased by 9% to $1.3 billion; up 8%
Resmed Inc. reported a revenue increase of 9% to $1.3 billion for the first quarter of fiscal year 2026, accompanied by a 16% growth in non-GAAP earnings per share. The company experienced significant gross margin expansion and emphasized its commitment to transforming home healthcare with advanced products and solutions. Resmed's strategic focus includes ongoing investments in innovation and operational excellence, asserting its vision for improved global health through accessible care. Additionally, the company declared a quarterly cash dividend of $0.60 per share for its shareholders.
Read more →RMDWhat is sleep apnea?
Sleep apnea is a serious condition characterized by repeated interruptions in breathing during sleep, which can lead to insufficient oxygen supply. There are three main types: obstructive, central, and complex sleep apnea, each with distinct causes and symptoms. Diagnosis typically involves consultations with healthcare professionals and sleep tests, while treatment options range from lifestyle changes to devices like CPAP therapy. Early detection and management are crucial to prevent long-term health complications.
Read more →RMDResmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025
Resmed has announced that it will release its financial and operational results for the first quarter of fiscal year 2026 on October 30, 2025. Following the release, a webcast will be hosted by management to discuss the results and other relevant information. A replay of the webcast will be available shortly after the event.
Read more →RMDResmed Announces Participation in the Bank of America Global Healthcare Conference 2025
Resmed has announced its participation in the Bank of America Global Healthcare Conference 2025. CEO Mick Farrell and CMO Dr. Carlos Nunez will present on September 23, 2025, in London. The event will be accessible via a live audio-only webcast, with a replay available for 30 days post-event.
Read more →RMDResmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority
Resmed has launched the Sleep Institute, a global initiative aimed at enhancing sleep health through clinical insights and collaborations. The initiative seeks to address the underdiagnosis of sleep disorders, particularly obstructive sleep apnea (OSA), by providing evidence-based research and data. The Sleep Institute will debut at the World Sleep Congress, emphasizing the need for better integration of sleep health into healthcare systems.
Read more →RMDObstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds
A new study by Resmed projects that obstructive sleep apnea (OSA) will affect nearly 77 million U.S. adults by 2050, marking a 35% increase from 2020. The research emphasizes the need for earlier diagnosis and treatment due to the serious health risks associated with OSA. It calls for expanded screening and awareness to address this growing public health issue.
Read more →RMDResmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs
Resmed has announced that its AirTouch N30i nasal cradle mask has won two prestigious Red Dot Awards for design, highlighting its innovative features aimed at improving patient comfort and adherence to CPAP therapy. The mask utilizes a unique fabric-silicone cushion and design elements that enhance breathability and comfort. Additionally, Resmed boasts a significant portfolio of patents, reinforcing its commitment to innovation in sleep and respiratory care.
Read more →RMDResmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio
Resmed has elected Nicole Mowad-Nassar to its board of directors, effective August 15, 2025. Mowad-Nassar, currently President of Specialty and U.S. Therapeutics Operations at AbbVie, will bring extensive experience in commercial strategy and digital health. The company also announced the retirement of Rich Sulpizio, who has served on the board since 2005, effective after the 2025 Annual Meeting.
Read more →RMDFor investors For media +1 858.836.5971 +1 619.510.1281 investorrelations@resmed.com news@resmed.com Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio Mowad-N
Resmed has announced the election of Nicole Mowad-Nassar to its board of directors, effective August 15, 2025. Mowad-Nassar, currently President of Specialty and U.S. Therapeutics Operations at AbbVie, brings significant experience in commercial strategy and digital health innovation. The company also noted the retirement of board member Rich Sulpizio, who has been with Resmed for two decades, effective after the upcoming Annual Meeting of Stockholders in November 2025. This leadership transition is seen as a positive step for the company's future direction.
Read more →RMDFor investors For media +1 858-836-5000 +1 619-510-1281 investorrelations@resmed.com news@resmed.com Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2025 Year-over-year revenue grows 10%, operating pr
Resmed Inc. announced its financial results for the fourth quarter of fiscal year 2025, showcasing a 10% increase in revenue compared to the previous year. The company reported a 23% growth in non-GAAP earnings per share, alongside a significant rise in net income. Resmed's CEO emphasized the ongoing momentum due to robust global demand and innovation in sleep and breathing health devices. The future outlook remains positive as the company continues to invest in its digital health ecosystem and enhance access to care worldwide.
Read more →RMDResmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2025
Resmed Inc. reported a strong performance for the fourth quarter of fiscal year 2025, with revenues increasing by 10% to $1.3 billion. Operating profit grew by 19%, fueled by robust demand for sleep and breathing health devices. The company announced a quarterly dividend increase of 13% to $0.60 per share. Additionally, significant growth was observed in the full fiscal year 2025, with net income rising by 37% attributed to effective cost management and operational efficiencies.
Read more →RMDResmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025
Resmed has announced that it will release its financial and operational results for the fourth quarter of fiscal year 2025 on July 31, 2025. The results will be disclosed after market close, followed by a management-hosted webcast to discuss the findings and any relevant information. The earnings call will be accessible via a specific webcast link and will also be available for replay afterward on the company's investor relations website.
Read more →RMDResmed Champions Sleep Health as The Official Sleep Partner of The Qatar Airways British & Irish Lions Tour to Australia 2025
Resmed has been named the Official Sleep Partner for the Qatar Airways British & Irish Lions Tour to Australia in 2025. The partnership aims to promote sleep health through the 'Tackle Your Sleep' campaign, featuring rugby legends sharing insights on improving sleep quality. This initiative highlights the importance of sleep for athletes and fans alike, as it plays a crucial role in performance and overall well-being.
Read more →RMDReal talk about sleep apnea: a Q&A with model and influencer Remi Bader
Remi Bader discusses her experience with obstructive sleep apnea, revealing how she was diagnosed and the positive impact of using a CPAP machine. Through her partnership with Resmed, she aims to raise awareness and reduce stigma surrounding sleep apnea. Bader encourages others to prioritize their health and seek treatment if they suspect they have sleep apnea.
Read more →RMDResmed Acquires VirtuOx
Resmed has acquired VirtuOx, an independent diagnostic testing facility, to enhance its home healthcare offerings. This acquisition aims to improve care delivery by making it more accessible and coordinated, particularly for patients with sleep-related issues. VirtuOx's virtual testing platform is expected to help streamline the diagnostic process and reduce barriers to treatment. Following the acquisition, VirtuOx will operate as a subsidiary of Resmed, maintaining its brand while continuing to innovate in the healthcare space.
Read more →RMDFor investors For media +1 858-836-5000 +1 619-510-1281 investorrelations@resmed.com news@resmed.com Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025 Year-over-year revenue grows 8%, operating prof
Resmed Inc. announced its third quarter results for fiscal year 2025, showing an 8% increase in revenue compared to the previous year. The company's gross margin improved, and it achieved a 14% growth in income from operations. Moreover, Resmed plans to continue its outreach to increase patient access to its sleep health and digital health solutions. A quarterly cash dividend was also declared, further signaling the company's financial health.
Read more →RMDResmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025
Resmed Inc. has reported strong third-quarter results for fiscal year 2025, with a revenue increase of 8% year-over-year, totaling $1.3 billion. Operating profit rose by 14%, and diluted earnings per share increased by 22% to $2.48. The company highlighted ongoing customer demand for its sleep and breathing health products, contributing to improved gross margins. Additionally, Resmed announced the launch of its FDA-cleared home sleep apnea test, NightOwl, which aims to simplify sleep apnea diagnosis for healthcare providers and patients.
Read more →RMDResmed Names Salli Schwartz as Chief Investor Relations Officer
Resmed has announced the appointment of Salli Schwartz as Chief Investor Relations Officer, effective April 21, 2025. Schwartz brings extensive experience from her previous role at Illumina, where she was instrumental in investor engagement and corporate strategy. In her new position, she will oversee Resmed's global investor relations and support the company’s 2030 strategy aimed at enhancing shareholder value. Resmed's CEO, Mick Farrell, emphasized the importance of Schwartz's leadership in achieving their goals.
Read more →RMDResmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US
Resmed has announced the availability of NightOwl™, a new home sleep apnea test that offers a simplified and effective way to diagnose obstructive sleep apnea (OSA) in the United States. NightOwl is an FDA-cleared device that can record sleep data for up to ten nights, with results being analyzed by healthcare providers through a cloud-based platform. The device aims to improve accessibility to OSA testing and is designed for easy use by both patients and clinicians. NightOwl features auto-scored results and integrates with Resmed's existing health technology.
Read more →RMDResmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025
Resmed has announced that it will release its third quarter fiscal 2025 earnings on April 23, 2025, after market hours. A webcast will follow the announcement, where management will discuss the results and additional material information. The company emphasizes its dedication to improving health technologies and aims to provide accessible and effective healthcare solutions globally.
Read more →RMDResmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution
Resmed has announced a comprehensive brand evolution to unify its portfolio and enhance its role in the global health tech sector. This transformation is aimed at addressing the widespread issues of sleep disorders, emphasizing a proactive approach to sleep and breathing health. The company plans to implement targeted consumer and healthcare provider campaigns to reshape perceptions of sleep therapy and improve intervention rates. Resmed's new branding reflects its commitment to empowering individuals through innovative health technologies.
Read more →RMDResMed’s Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep
ResMed's fifth annual Global Sleep Survey reveals a significant global sleep crisis, with 70% of employed respondents having called in sick due to poor sleep at least once. The survey indicates that many people are unaware of sleep's critical health impact, with nearly a quarter opting to live with sleep issues rather than seek solutions. Results show a noticeable disparity in sleep experiences between genders, with women reporting lower sleep quality compared to men. The findings emphasize the urgent need for increased awareness and actionable steps to improve sleep health worldwide.
Read more →RMDResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2025
ResMed Inc. reported strong financial results for the second quarter of fiscal year 2025, featuring a 10% increase in revenue year-over-year, totaling $1.3 billion. Operating profit saw a remarkable rise of 52%, while diluted earnings per share reached $2.34, reflecting the company's operational efficiency and demand for its products. Noteworthy developments during the quarter include the launch of a new accessory for Apple Vision Pro and expansion efforts in Singapore. Overall, the results highlight ResMed's commitment to growth within the sleep and breathing health market.
Read more →RMDFor investors For media +1 858-836-5000 +1 619-510-1281 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2025 Year-over-year revenue grows 10%, operating pr
ResMed Inc. reported a strong second quarter for fiscal year 2025, highlighting a 10% increase in revenue compared to the previous year. Gross margins improved by 230 basis points, and the company achieved a net income rise of 65%, reaching $344.6 million. The positive results were attributed to heightened demand for their sleep and breathing health products, as well as advancements in digital health solutions. The company is well-positioned to leverage growing opportunities in connected health technologies.
Read more →RMDResMed to Report Second Quarter Fiscal 2025 Earnings on January 30, 2025
ResMed has announced it will release its financial and operational results for the second quarter of fiscal year 2025 on January 30, 2025, after market close. The company will host a webcast to discuss the results, which aims to provide insights on forward-looking information. Shareholders and interested parties can access the webcast through ResMed's investor relations website. A replay of the webcast will also be available for further review.
Read more →RMDRestful resolutions: 2024 sleep habits and sleep priorities for the New Year
A recent survey highlights that while one-third of Americans feel their sleep quality is good, many struggle with stress and anxiety affecting their rest. As 2025 approaches, individuals are setting resolutions to improve their sleep habits, including establishing consistent sleep schedules and reducing screen time. The emphasis on sleep as a crucial aspect of health is growing, with many prioritizing better sleep in the new year.
Read more →RMDResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference
ResMed has announced the participation of its executives, Mick Farrell and Dr. Carlos Nunez, at the upcoming 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on January 13, 2025. The event will include a live audio-only webcast, with a replay available for 30 days post-event. This participation highlights ResMed's commitment to innovation in healthcare, focusing on solutions for chronic diseases like sleep apnea and COPD. The company emphasizes its role in empowering healthier lifestyles through advanced digital health technologies and cloud-connected devices.
Read more →RMDAPAP vs CPAP: Sleep apnea treatments explained
The article explains the differences between APAP and CPAP, two types of positive airway pressure therapy for sleep apnea. APAP, or automatic positive airway pressure, adjusts the air pressure delivered based on the patient's breathing needs, unlike CPAP, which provides a constant pressure. This adaptability may benefit patients with complex sleep apnea conditions.
Read more →RMDWhat happens if you can’t sleep during a sleep test?
The article discusses concerns about sleeping during a prescribed sleep test, whether in a lab or at home. It reassures readers that many people do manage to sleep, despite initial anxiety. Sleep labs are designed to be comfortable, allowing personal items to enhance relaxation. If adequate sleep isn't achieved, retesting may be necessary.
Read more →RMDWhat are the benefits of sleep apnea support groups?
The article discusses the benefits of sleep apnea support groups, emphasizing their role in providing guidance and encouragement for individuals undergoing treatment. Both in-person and online groups are highlighted as valuable resources for sharing experiences and learning about CPAP therapy. The support from these groups can enhance comfort and confidence in managing sleep apnea.
Read more →RMDUsing two CPAP masks
The article discusses the benefits of using two CPAP masks alternately for better treatment outcomes. It highlights situations such as environmental allergies, facial sensitivity, and recovery from surgery where this approach may be beneficial. Readers are encouraged to consult with their equipment suppliers for proper fitting and maintenance of their CPAP supplies.
Read more →RMDTraveling with CPAP: Do you need a CPAP travel bag or case?
The article discusses the importance of using CPAP travel bags for patients with sleep apnea. It highlights various options available, particularly from Resmed, and emphasizes the need for proper power supplies when traveling. The piece reassures readers that traveling with CPAP equipment has become easier with the right tools and accessories.
Read more →RMDTravel CPAP solutions: Do you need a travel CPAP machine?
The article discusses the portability of CPAP machines for travel, emphasizing that most modern devices can be easily transported and used in various locations, including hotels and airplanes. It highlights the Resmed AirMini™ as an excellent lightweight option for frequent travelers. Additionally, it reassures users that their CPAP machines can function with battery power and in different countries.
Read more →RMDTravel CPAP battery: Your personal road warrior
The article discusses the importance of using CPAP machines while traveling and highlights the benefits of portable CPAP batteries, specifically the Resmed Power Station II. This battery is lightweight, powerful, and charges quickly, making it ideal for various travel scenarios. It also provides guidance on how to travel with CPAP equipment and the necessary preparations for in-flight use.
Read more →RMDHow to track sleep apnea treatment using myAir
The article discusses the benefits of using Resmed's myAir application to track sleep apnea treatment. It highlights how myAir connects to CPAP machines to provide users with insights on their therapy, including usage duration and mask performance. The app simplifies data interpretation and encourages users by sending congratulatory messages upon achieving goals. It is available for free registration in the US and Canada.
Read more →RMDTop 5 sleep apnea myths: Busted!
The article debunks five prevalent myths about sleep apnea, emphasizing that it is not solely caused by obesity, and that snoring does not equate to a diagnosis. It highlights that both oversleeping and undersleeping can be harmful, and that children can also suffer from sleep apnea. Additionally, it reassures that using a CPAP mask can enhance appearance.
Read more →RMDTime for a new CPAP machine?
The article discusses the importance of replacing CPAP machines approximately every five years, highlighting advancements in technology and comfort. It outlines the benefits of new machines, including quieter operation, lower pressures, and better humidification. Additionally, it provides guidance on obtaining a new machine and disposing of the old one responsibly.
Read more →RMDThe sleep lab experience: What you need to know about sleep tests?
The article addresses common fears and questions about sleep apnea tests, emphasizing their importance for diagnosis and treatment. It explains that while some may not require a sleep test, consulting a doctor is crucial for proper evaluation. The piece also highlights the comfort of sleep study environments and the potential life-changing benefits of treatment.
Read more →RMDThe NFL and sleep apnea connection: Facts
The article discusses the connection between sleep apnea and NFL players, emphasizing that over 60% of former players may suffer from the condition. It highlights studies from the Mayo Clinic linking sleep apnea to obesity and cardiovascular risks in retired athletes. Notable cases, such as Reggie White's death, are mentioned to underscore the severity of the issue.
Read more →RMDThe effects of sleep deprivation on your health
The article discusses the numerous effects of sleep deprivation on health, highlighting both short-term and long-term risks. Key issues include increased susceptibility to serious health conditions, impaired decision-making, and negative impacts on memory and appetite. The article emphasizes the importance of understanding these effects, especially for those who frequently sacrifice sleep for work or study.
Read more →RMDThe effects of insomnia and chronic insomnia
Insomnia is a prevalent sleep disorder affecting millions in the U.S., with chronic insomnia impacting quality of life and productivity. Factors contributing to chronic insomnia include mental health issues and lifestyle choices. The article highlights the need for awareness and understanding of insomnia's effects and potential treatment options.
Read more →RMDThe CPAP mask that brings couples together again
The article highlights the benefits of the AirFit P10 nasal pillow mask for CPAP therapy users. Patients report significant improvements in sleep quality, including the ability to sleep next to their partners again. The mask is noted for its lightweight and quiet design, earning a prestigious Red Dot Award. This innovation aims to enhance therapy adherence and overall sleep experience.
Read more →RMD▼ -5.1%on this newsshared move
Stress and sleep apnea
The article explores the connection between stress and sleep apnea, suggesting that while stress can impact sleep health, the relationship with obstructive sleep apnea (OSA) is mostly indirect. It emphasizes the importance of managing stress to improve overall sleep quality. The article also provides tips for reducing stress to promote better sleep.
Read more →RMD▼ -5.1%on this newsshared move
Stacy’s Story: How this business owner conquered sleep apnea
Stacy shares her journey of living with undiagnosed sleep apnea for 16 years before receiving a diagnosis. After starting CPAP therapy, she experienced increased energy but found the bulky machine inconvenient. The introduction of the Resmed AirMini™, a portable CPAP device, provided her with newfound freedom and convenience, especially as a busy mom and business owner.
Read more →RMD▼ -5.1%on this newsshared move
Spring cleaning tips for CPAP users
The article provides spring cleaning tips specifically for CPAP users to enhance their sleep quality and therapy effectiveness. It emphasizes the importance of regularly cleaning CPAP equipment and maintaining a tidy living space to reduce allergens. The piece also suggests lifestyle changes to improve overall therapy and sleep hygiene, making a case for the benefits of a clean environment.
Read more →RMDSleep robbers: RLS and periodic limb movement disorder
The article discusses Restless Legs Syndrome (RLS) and Periodic Limb Movement Disorder (PLMD), both affecting approximately 10% of adults. RLS causes uncomfortable sensations leading to an urge to move, while PLMD involves involuntary movements during sleep. Both disorders can disrupt sleep and are more common in women and older adults. Treatment options exist, though there is no cure.
Read more →RMDSleep myth: Getting 4 hours of sleep is enough
The article debunks the myth that four hours of sleep is sufficient for healthy living. It emphasizes that while some individuals may function on less sleep, the National Sleep Foundation recommends 7-8 hours for optimal health. The article encourages readers to evaluate their own sleep needs and consult a doctor if they experience daytime fatigue.
Read more →RMDSleep myth #3: CPAP isn’t sexy
The article discusses how CPAP therapy can positively impact intimate relationships by improving sleep quality. Nancy Brewer shares her personal experience, highlighting that CPAP has allowed her and her husband to reconnect and enjoy more quality time together. The therapy not only helps with sleep apnea but also enhances libido and intimacy.
Read more →RMDSleep deprivation in teenagers: A sign of sleep apnea?
A recent UK study highlights that over half of teenagers experience sleep deprivation, raising concerns about its link to sleep apnea. Experts emphasize the significant impact of lack of sleep on teens, including academic performance and mental health. Recommendations for parents include establishing sleep routines and reducing distractions before bedtime to combat this issue.
Read more →RMDSleep deprivation effects on the brain
The article discusses the significant effects of sleep deprivation on brain function, highlighting its impact on memory, mood, and decision-making. Research indicates that both chronic and acute sleep loss can lead to cognitive impairments and emotional instability. It emphasizes the importance of maintaining adequate sleep for overall brain health and functioning.
Read more →RMDSleep apnea symptoms in women: Are they different?
A recent study from UCLA indicates that sleep apnea symptoms in women differ from those in men, often leading to misdiagnosis. Women may present with subtler symptoms, such as chronic fatigue and insomnia, rather than classic signs like snoring. This underdiagnosis can result in more severe health risks, including heart disease. Early detection and treatment are crucial for women's health.
Read more →RMDSleep apnea symptoms in women
The article discusses the unique symptoms of sleep apnea in women, highlighting that they can differ significantly from those in men. It notes that nearly 40% of sleep apnea patients are female, up from 30% a decade ago, yet many women remain undiagnosed due to subtler symptoms. The article emphasizes the importance of awareness and encourages women experiencing these symptoms to seek medical advice.
Read more →RMDSleep apnea solutions: Pre- and post-diagnosis options
The article discusses various solutions for managing sleep apnea, both pre- and post-diagnosis. It emphasizes the importance of consulting a physician for proper diagnosis and treatment. Preventive measures such as weight loss and maintaining a regular sleep schedule are highlighted, alongside treatment options like CPAP therapy, oral appliances, and surgery. The article also notes the limitations of surgical interventions.
Read more →RMDSleep apnea side effects: An overview
The article discusses the side effects of sleep apnea, including depression and fatigue, which can significantly impact daily life. It highlights that while CPAP therapy is commonly prescribed and can alleviate some symptoms, it also has its own side effects, primarily related to the mask. Surgical options are considered riskier, with many patients experiencing persistent side effects. Overall, understanding these effects is crucial for effective management.
Read more →RMDSleep apnea in children
Sleep apnea is a condition that can affect children, though it is less common than in adults. Symptoms include loud snoring, pauses in breathing, and daytime sleepiness. Enlarged tonsils are often a contributing factor, and treatment options like tonsillectomy can improve sleep quality. Parents are encouraged to monitor symptoms and consult a physician if concerns arise.
Read more →RMDSleep apnea comorbidities: An overview
The article discusses the comorbidities associated with sleep apnea, emphasizing its connections to serious health conditions such as diabetes, heart disease, stroke, and cancer. It highlights the prevalence of these comorbidities and their implications for patient health. The article also mentions additional conditions like obesity and PTSD that may exacerbate the risks.
Read more →RMDSleep apnea causes: Understanding your risk levels
The article discusses the various causes of sleep apnea, emphasizing the importance of understanding personal risk factors. Key contributors include obesity, gender, age, neck size, and lifestyle choices such as smoking and alcohol use. It highlights that more than 18 million Americans suffer from sleep apnea, prompting ongoing innovation in treatment devices. The article encourages readers to consult with healthcare professionals regarding their risk levels.
Read more →RMDSleep apnea and pregnancy: What’s the relationship?
The article discusses the relationship between sleep apnea and pregnancy, highlighting that pregnant women are more susceptible to sleep-related conditions. It cites studies indicating that sleep apnea can lead to complications such as preeclampsia and increased cesarean deliveries, especially among obese women. The importance of adequate sleep and potential treatments for sleep apnea prior to pregnancy are emphasized.
Read more →RMDSleep apnea and obesity: What’s the connection?
The article explores the connection between obesity and obstructive sleep apnea (OSA), highlighting that obesity increases the risk of developing OSA and vice versa. It emphasizes the importance of a holistic treatment approach, combining weight loss, lifestyle changes, and CPAP therapy. The article also notes the potential risks associated with untreated OSA and obesity.
Read more →RMDGlaucoma and the connection between sleep apnea
The article discusses the potential connection between sleep apnea and glaucoma, highlighting that while many studies suggest an increased risk of glaucoma in sleep apnea patients, conclusive evidence is lacking. Experts emphasize the importance of screening for glaucoma in those with sleep apnea, as treating the latter may help mitigate risks associated with glaucoma. However, conflicting studies exist, and the exact mechanisms remain unclear.
Read more →RMDSleep apnea and exercise: The sleep/health connection
The article discusses the connection between sleep apnea and exercise, highlighting that regular physical activity leads to better sleep quality. A National Sleep Foundation poll revealed that 67% of exercisers report good sleep compared to only 39% of non-exercisers. Additionally, exercise aids in weight control, which is crucial for preventing obstructive sleep apnea. The findings suggest revising sleep hygiene recommendations to include exercise at any time of day.
Read more →RMDSleep apnea and bradycardia
The article explores the relationship between sleep apnea and bradycardia, highlighting that bradycardia, defined as a slow heart rate, is often associated with sleep apnea. It discusses how sleep apnea can lead to bradycardia due to oxygen deprivation and emphasizes the importance of understanding this connection, especially in infants. The article also outlines potential causes and treatments for these conditions.
Read more →RMDSleep apnea and blood pressure: What’s the connection?
The article discusses the established link between sleep apnea and high blood pressure, emphasizing that untreated sleep apnea can increase the risk of hypertension and other cardiovascular issues. It references findings from the National Heart, Lung, and Blood Institute, the Mayo Clinic, and the UK's National Health Service, which all highlight the importance of addressing blood pressure concerns in patients with sleep apnea. The article underscores the need for patients to consult their doctors about these risks.
Read more →RMDSleep apnea and back pain: Sleep/health connection
The article discusses the connection between sleep apnea and back pain, emphasizing that while one does not cause the other, they often coexist. It highlights how untreated sleep apnea can exacerbate back pain and vice versa. The article also suggests that treating one condition may alleviate the symptoms of the other, recommending lifestyle changes such as exercise and hot baths.
Read more →RMDSigns of sleep apnea: An overview
The article provides an overview of the common signs of sleep apnea, including snoring, excessive daytime sleepiness, headaches, and nighttime sweating. It emphasizes the importance of recognizing these symptoms for early diagnosis and treatment. The article also mentions additional symptoms that may indicate sleep apnea, encouraging readers to consult a doctor if they experience these signs.
Read more →RMDShould I get a CPAP battery?
The article discusses the importance of CPAP batteries for users who travel or face power outages. Resmed Clinical Education Specialist Susie Justus provides insights on battery functionality, travel tips, and insurance coverage. It emphasizes the need for CPAP users to be prepared for various situations to ensure uninterrupted sleep therapy.
Read more →RMDWhat is severe sleep apnea and how do you treat it?
Severe sleep apnea is classified by the apnea-hypopnea index (AHI), with 30 or more events per hour indicating severity. This condition is associated with significant health risks, including a higher likelihood of cancer-related mortality. Recent studies suggest that untreated severe apnea can lead to increased death rates, emphasizing the need for diagnosis and treatment.
Read more →RMDReggie White’s legacy & sleep apnea awareness
Reggie White's legacy lives on through his foundation, which raises awareness about sleep apnea. After his untimely death due to cardiac arrhythmia linked to untreated sleep apnea, the Reggie White Sleep Disorders Research & Education Foundation was established to support individuals in managing their condition. The foundation has provided CPAP machines to over 300 people, emphasizing the importance of treatment and awareness.
Read more →RMDPTSD and sleep apnea: How they are related
Recent studies highlight a significant connection between PTSD and sleep apnea, suggesting that effective treatment of sleep apnea with CPAP can alleviate PTSD symptoms. Research indicates that sleep disturbances can exacerbate PTSD, creating a cycle of worsening symptoms. Notably, patients adhering to CPAP therapy report substantial improvements in their PTSD symptoms.
Read more →RMDPoor sleep hurts – literally
Recent research involving over 10,000 Norwegians shows that poor sleep quality significantly reduces pain tolerance. The study found that individuals with insomnia were more likely to withdraw their hands from cold water sooner than healthy sleepers. The findings emphasize the need for better sleep management, especially for those with sleep disorders like insomnia and sleep apnea.
Read more →RMDPLMD and RLS treatment options
The article discusses treatment options for restless legs syndrome (RLS) and periodic limb movement disorder (PLMD), highlighting the importance of addressing underlying medical conditions and making lifestyle changes. It emphasizes the role of medications while cautioning about potential side effects and interactions, particularly for patients with obstructive sleep apnea. Consulting a doctor is crucial for personalized treatment plans.
Read more →RMDRestful sleep & pets: Can they coexist?
The article discusses the coexistence of pets and sleep, highlighting that many pet owners allow their pets to sleep in their beds. While pets can provide comfort and reduce anxiety, they may also disrupt sleep, especially in households with multiple pets. The article offers tips for maintaining sleep health while sharing a bed with pets, emphasizing hygiene and routines.
Read more →RMDPediatric CPAP: Exploring CPAP for kids
Pediatric CPAP therapy is essential for children with severe obstructive sleep apnea not resolved by other treatments. While rare, CPAP can significantly improve sleep quality and overall health. Specialized pediatric masks, like the Resmed Pixi™, enhance comfort and acceptance. Parents are encouraged to establish routines to help children adapt to wearing the mask nightly.
Read more →RMDOur best tips for helping you sleep well this winter
As winter approaches, individuals with obstructive sleep apnea (OSA) may experience worsened symptoms due to colder temperatures. A Brazilian study indicates increased nighttime breathing stoppages during winter months. To combat these issues, the article offers practical tips such as using a CPAP humidifier, maintaining a cool sleeping environment, and ensuring morning light exposure to improve sleep quality.
Read more →RMDOSA and COPD overlap syndrome: What to know
The article discusses the overlap syndrome between obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD), affecting at least 10% of OSA patients. It highlights the increased risks associated with this combination, particularly low oxygen levels at night. The article emphasizes the importance of early diagnosis and treatment options for managing both conditions effectively.
Read more →RMDNot your father’s sleep apnea mask: 4 reasons to give new CPAP masks a try
The article discusses the evolution of CPAP masks for sleep apnea therapy, highlighting four key reasons to try modern options. These new masks are designed to be smaller, lighter, and more comfortable, making them easier to use. They allow for freedom of movement during sleep and feature quiet technology to minimize noise. Overall, these advancements aim to improve the user experience and encourage more people to engage in CPAP therapy.
Read more →RMDNew treatment for sleep apnea symptoms in women
Resmed has launched the AirSense™ 10 AutoSet for Her, a treatment specifically designed for women with obstructive sleep apnea (OSA). This device addresses unique female characteristics of OSA, such as longer sleep onset and flow limitations. The AutoSet for Her features AutoRamp™ for gradual pressure adjustment, enhancing comfort and compliance. Clinical trials indicate significant improvements in treatment effectiveness.
Read more →RMDNatural sleep aids: Do they really work?
The article discusses the effectiveness of natural sleep aids for conditions like insomnia and sleep apnea. While these aids are popular, clinical evidence supporting their efficacy is limited. Common aids such as chamomile, valerian, and melatonin are mentioned, with varying degrees of reported effectiveness. The article also highlights the lack of FDA regulation for these products, raising safety concerns.
Read more →RMDGuide to different narcolepsy treatment options
The article provides an overview of narcolepsy treatment options, emphasizing that while there is no cure, various medications and lifestyle changes can help manage symptoms. It categorizes treatments into lifestyle modifications and medications, highlighting the importance of both approaches. Key medications include stimulants and antidepressants, but they may have side effects that require careful management.
Read more →RMDNaps and sleep disorders: The connection
Recent research highlights the benefits and drawbacks of daytime naps for individuals with sleep disorders. While naps can enhance memory and alertness, they may be detrimental for those with conditions like sleep apnea and insomnia. Conversely, naps are beneficial for individuals with narcolepsy, aiding their daily functioning. It's crucial for those with sleep disorders to consult their doctors regarding napping.
Read more →RMDMy dog snores: Does he have sleep apnea?
The article discusses obstructive sleep apnea in pets, particularly dogs and cats. It highlights that pets can develop sleep apnea due to various factors, including obesity and anatomical issues. While CPAP has shown promise in treating cats, it is not yet an option for dogs. The article emphasizes the importance of veterinary consultation for pets showing symptoms of sleep disorders.
Read more →RMDModerate sleep apnea treatment options
The article discusses treatment options for moderate sleep apnea, emphasizing lifestyle changes as a primary approach. It suggests weight loss, tobacco cessation, alcohol reduction, and changing sleep habits as effective strategies. The article also notes that advanced therapies like CPAP may be considered if symptoms persist. Overall, it provides actionable advice for managing the condition.
Read more →RMDModerate sleep apnea symptoms and OSA
The article discusses moderate sleep apnea, a condition characterized by frequent awakenings during sleep. It outlines common symptoms, such as excessive daytime sleepiness, loud snoring, and difficulty concentrating. The piece emphasizes the importance of recognizing these symptoms and consulting a doctor for potential treatment. Future articles will cover treatment options for moderate sleep apnea.
Read more →RMDMild to moderate sleep apnea
The article discusses mild to moderate sleep apnea, defining it based on the apnea-hypopnea index (AHI). It explains the classification of sleep apnea severity and the rationale behind combining mild and moderate cases for treatment purposes. The article also highlights the importance of consulting a doctor if symptoms are present.
Read more →RMDMild sleep apnea definition and symptoms
Mild sleep apnea is defined as the least severe form of obstructive sleep apnea, characterized by 5 to 15 breathing interruptions per hour. Symptoms include loud snoring, daytime sleepiness, and potential links to high blood pressure or diabetes. Awareness and treatment options are crucial to prevent progression to more severe forms of sleep apnea.
Read more →RMDMild sleep apnea: Treatment options
The article discusses treatment options for mild sleep apnea, emphasizing that they differ from those for moderate or severe cases. While CPAP therapy is commonly prescribed, it is often recommended only after lifestyle changes, such as weight loss and changing sleep positions, have been attempted. The article highlights the importance of addressing mild sleep apnea with appropriate methods.
Read more →RMDManual mode: Know your CPAP humidifier
The article discusses the importance of CPAP humidifiers in enhancing user comfort during sleep. It explains how to access and utilize the Climate Control Manual mode on Resmed CPAP machines, allowing users to adjust humidity and tube temperature settings. The article emphasizes the benefits of personalized adjustments to improve breathing comfort and reduce dryness.
Read more →RMDSleeping with a CPAP: 7 tips for a better experience
The article offers seven practical tips for individuals adjusting to CPAP therapy for sleep apnea. It emphasizes the importance of consistent use and provides strategies for comfort, such as mask adjustments and using a humidifier. Additionally, it highlights the benefits of using the myAir app for personalized support. Overall, these tips aim to enhance the CPAP experience and improve sleep quality.
Read more →RMDI use CPAP. Why do I still have apneas?
The article discusses why CPAP users may still experience apneas despite treatment. It explains that having an AHI above zero can be normal and that users can still benefit from CPAP even with mild sleep apnea. The article emphasizes the importance of discussing AHI goals with a doctor and monitoring symptoms beyond AHI.
Read more →RMDIs there a sleep apnea cure?
The article discusses the treatment options for sleep apnea, highlighting that there is no definitive cure for central sleep apnea and that surgery for obstructive sleep apnea is highly invasive. It emphasizes the importance of consulting a doctor for personalized treatment plans and mentions various lifestyle changes that may alleviate symptoms but are not cures. The article also notes that CPAP remains the gold standard in treatment.
Read more →RMDIs there a cure for sleep apnea?
The article discusses the lack of a definitive cure for sleep apnea, emphasizing that treatments like CPAP therapy and weight loss can alleviate symptoms. While weight loss may significantly improve conditions for those with obstructive sleep apnea, it is not a guaranteed cure. Overall, the focus should be on managing the condition and improving overall health.
Read more →RMDThe link between sleep apnea and depression
The article discusses the link between sleep apnea and depression, noting that both conditions share symptoms, complicating diagnosis. It emphasizes the importance of screening for sleep apnea in individuals experiencing depressive symptoms. The article encourages readers to consult their doctors for potential sleep studies and treatment options.
Read more →RMDIs sleep apnea hereditary?
The article discusses the hereditary aspects of sleep apnea, emphasizing that genetic factors, along with lifestyle choices, can increase the risk of developing the condition. It highlights symptoms to watch for, such as loud snoring and daytime sleepiness, and suggests consulting a doctor if there is a family history of sleep apnea. The piece also notes that both children and adults can be affected by this disorder.
Read more →RMDIs sleep apnea dangerous?
The article discusses the dangers of untreated sleep apnea, emphasizing its potential to cause serious health issues like high blood pressure and stroke. It encourages individuals to recognize symptoms such as excessive daytime sleepiness and loud snoring. Early diagnosis and management are crucial for reducing health risks associated with the condition.
Read more →RMDIs a little sleep debt ok?
Researchers from Weill Cornell Medical College presented findings at the Endocrine Society's conference, indicating that even a small amount of sleep debt can significantly increase the risk of obesity and type 2 diabetes. The study found that losing just 30 minutes of sleep weekly can lead to a higher likelihood of these conditions. The article emphasizes the importance of prioritizing sleep for overall health and well-being.
Read more →RMDIntroducing the AirFit™ P10, Resmed’s quietest CPAP mask yet
Resmed has launched the AirFit P10, its quietest CPAP mask to date, which is 50% quieter and lighter than the Swift FX model. A clinical study revealed that over 70% of patients preferred the AirFit P10 for its comfort and stability, leading to longer sleep durations. The mask features advanced design elements, including QuietAir venting and QuickFit headgear, aimed at enhancing the user experience.
Read more →RMDDoes sleep apnea cause insomnia?
The article discusses the relationship between insomnia and sleep apnea, noting that individuals with one condition often experience the other. It outlines common causes of insomnia and offers tips for improving sleep hygiene. Additionally, it suggests taking a quiz to assess the risk of sleep apnea and emphasizes the importance of consulting a physician for diagnosis.
Read more →RMDSleep apnea humidifiers: Complying with treatment
The article discusses the importance of humidifiers in CPAP therapy for sleep apnea. A study led by Dr. Andreas Palm revealed that patients using humidifiers are 43% less likely to discontinue treatment. The research highlights a significant increase in the prescription of CPAP machines with built-in humidifiers, emphasizing their role in improving patient compliance.
Read more →RMDHow well are you really sleeping?
The article discusses the importance of recognizing and treating sleep disorders. It highlights the symptoms of various disorders, including obstructive sleep apnea and insomnia, and emphasizes the need for proper diagnosis and treatment. Improved sleep quality can lead to better health outcomes and quality of life. The article encourages individuals to seek help if they suspect they have a sleep disorder.
Read more →RMDHow to sleep without snoring
The article discusses common causes of snoring, particularly focusing on obstructive sleep apnea (OSA). It emphasizes the importance of recognizing symptoms associated with OSA and offers practical tips for reducing snoring, such as changing sleep posture and lifestyle modifications. The article encourages readers to consult a physician for proper diagnosis and treatment options.
Read more →RMDHow soon after starting treatment will I notice an improvement?
The article discusses the variability in improvement timelines for sleep apnea patients undergoing PAP therapy. Factors such as the severity of sleep apnea, duration of the condition, and proper mask fit influence outcomes. It emphasizes the importance of consistent device usage and consulting healthcare providers for optimal results.
Read more →RMDHow is sleep apnea diagnosed?
Sleep apnea is primarily diagnosed through a sleep test, which can be conducted in a lab or at home. The test involves wearing sensors while sleeping to monitor breathing patterns and heart rate. Family history and symptoms also assist in diagnosis. Early detection is crucial to avoid serious health risks.
Read more →RMDHow do I get rid of my congestion?
The article discusses common causes of congestion in sleep apnea patients and offers solutions. It emphasizes the importance of humidification in PAP therapy and suggests consulting healthcare providers for personalized treatment. Adjustments to temperature and humidity levels, as well as changing masks, are recommended. The article also highlights potential allergy-related congestion and the need for regular maintenance of equipment.
Read more →RMDHow do I find out if I have sleep apnea?
The article discusses signs of sleep apnea and the importance of consulting a doctor if symptoms are present. It highlights that untreated sleep apnea can lead to serious health issues, but it is manageable with treatment. The article encourages readers to assess their risk and support others who may show symptoms.
Read more →RMDHow common is sleep apnea and who is at risk?
Sleep apnea is a prevalent condition affecting people of all ages and genders, contrary to common misconceptions. Symptoms include loud snoring, daytime sleepiness, and morning headaches. Many remain undiagnosed, leading to serious health risks. Effective treatments are available, and awareness is crucial for better management of the condition.
Read more →RMDSleep apnea therapy: A guide for the newly diagnosed
The article provides guidance for individuals newly diagnosed with sleep apnea, emphasizing the importance of coordinated care and support. It highlights CPAP therapy as a primary treatment option and offers resources to help patients navigate their treatment journey. The article also introduces the myAir app, which aids in managing therapy adherence.
Read more →RMDHealthy sleep habits
The article outlines several tips for establishing healthy sleep habits, including maintaining a regular sleep schedule, creating a relaxing bedtime routine, and managing stress. It emphasizes the importance of a conducive sleep environment and suggests avoiding stimulants like caffeine and nicotine before bedtime. Additionally, it highlights the benefits of natural sunlight and regular exercise for better sleep quality.
Read more →RMDHealthy habits that boost outdoor activity
The article emphasizes the health benefits of outdoor activities and provides practical tips for incorporating more outdoor time into daily routines. It suggests strategies such as exploring local parks, breaking up chores, and finding enjoyable outdoor hobbies. The piece advocates for investing in outdoor gear and adding music to enhance the experience, ultimately aiming to improve sleep and overall well-being.
Read more →RMDWhat is CPAP (Continuous Positive Airway Pressure)
CPAP, or continuous positive airway pressure, is a breathing therapy device primarily used for sleep apnea. It delivers air through a mask to ensure consistent breathing during sleep. The therapy has evolved with advancements in comfort and technology, making it a preferred option for many patients. Insurance coverage for CPAP treatment is also widely available.
Read more →RMDWhat is sleep-disordered breathing?
Sleep-disordered breathing (SDB) encompasses various conditions where breathing is disrupted during sleep, including obstructive, central, and mixed sleep apnea. Despite growing awareness, many individuals remain undiagnosed, leading to potential health risks. Other forms of SDB, such as upper airway resistance syndrome, can also cause significant sleep disturbances and are treated similarly to sleep apnea.
Read more →RMDWhat is the correlation between neck size and sleep apnea?
The article discusses the correlation between neck size and the risk of obstructive sleep apnea (OSA). It highlights that men with neck sizes of 17 inches or more and women with neck sizes of 16 inches or more may be at increased risk. The article explains how a thicker neck can lead to a narrower airway, contributing to breathing difficulties during sleep. It emphasizes the importance of consulting a doctor for proper assessment and potential sleep testing.
Read more →RMDWhat is the difference between obstructive sleep apnea and central sleep apnea?
The article explains the differences between obstructive sleep apnea (OSA) and central sleep apnea (CSA). OSA is characterized by airway blockage during sleep, leading to snoring and potential choking. In contrast, CSA occurs when the brain fails to signal the body to breathe, causing temporary breathing cessation. Both conditions can result in frequent awakenings at night.
Read more →RMDWhat is VPAP? Is it different than APAP and CPAP?
VPAP, or variable positive airway pressure, is a bilevel PAP device that offers two levels of air pressure for patients with sleep apnea. Unlike CPAP, which provides a constant pressure, VPAP allows for more customization and is particularly beneficial for those who struggle with CPAP therapy. It is also used for patients with additional respiratory conditions requiring ventilatory support.
Read more →RMDWhat’s the difference between CPAP and PEEP?
The article explains the differences between CPAP (Continuous Positive Airway Pressure) and PEEP (Positive End Expiratory Pressure). CPAP delivers air continuously, while PEEP provides air only at the end of an expiration. The distinction is important for clinicians but not typically a concern for sleep apnea patients using CPAP therapy.
Read more →RMDHealthy eating tips for your sleep apnea during football season
The article discusses how to maintain healthy eating habits during football season, especially for those with sleep apnea. It highlights unhealthy foods to avoid, such as refined carbohydrates and high-fat meats, and suggests healthier alternatives like grilled chicken and fruit. The aim is to help individuals enjoy game day without compromising their health.
Read more →RMDHang on to these healthy sleep habits
The article discusses the significance of maintaining healthy sleep habits, especially for individuals diagnosed with sleep apnea. It outlines various strategies to improve sleep quality, such as sticking to a sleep schedule, avoiding caffeine in the afternoon, and investing in a good mattress. The piece emphasizes that good sleep is crucial for both physical and mental health.
Read more →RMDHow to get rid of CPAP marks on my face
The article discusses common issues with CPAP masks, particularly the marks they leave on the face. It emphasizes the importance of ensuring a proper mask fit and adjusting headgear tension. Additionally, it suggests trying different mask types, like nasal pillows, for improved comfort. The article aims to help users wake up without facial marks.
Read more →RMDGet more comfortable in the cold
The article discusses the benefits of using humidification with CPAP therapy during cold weather. It highlights the Resmed Air 10 humidification system and its Climate Control feature, which adjusts humidity automatically for comfort. Tips are provided for manual adjustments and addressing potential issues like mask leaks. Overall, the article emphasizes the importance of humidification for better breathing and comfort.
Read more →RMDCan losing weight cure sleep apnea? Weight loss FAQ
The article discusses the relationship between weight loss and sleep apnea, clarifying that while weight loss can alleviate symptoms for some individuals with obstructive sleep apnea, it is not a cure. It emphasizes the importance of maintaining CPAP therapy and consulting a doctor before making changes to treatment. Healthy lifestyle choices, including diet and exercise, are encouraged to support overall health.
Read more →RMDFoods to avoid at night
The article discusses foods to avoid at night to improve sleep quality. It emphasizes the importance of avoiding caffeine, heavy meals, spicy foods, and alcohol close to bedtime. Additionally, it highlights the potential digestive issues caused by certain foods and suggests finishing eating at least two hours before sleep. The article aims to promote better sleep habits through dietary choices.
Read more →RMDFoods that help you sleep
The article discusses various foods that can help improve sleep quality. It highlights key nutrients such as L-tryptophan, calcium, carbohydrates, magnesium, and vitamin B6, detailing their sources and effects on sleep. The piece emphasizes the importance of incorporating these foods into the diet for better sleep health.
Read more →RMDFall asleep faster with lower CPAP pressure
Resmed's AutoRamp feature on AirSense 10 CPAP machines allows users to start at a lower air pressure while awake, making it easier to fall asleep. It automatically increases pressure once the user is detected to be asleep, ensuring effective treatment for sleep apnea. This innovation aims to enhance comfort and improve the overall CPAP experience.
Read more →RMDFACT or FICTION: Do women need more sleep than men?
Recent research from Loughborough University suggests that women may require more sleep than men due to differences in brain function and multitasking abilities. The study indicates that women use their brains more intensively, leading to a need for additional rest, potentially ranging from 20 minutes to more. Furthermore, poor sleep has been linked to higher distress and irritability in women compared to men.
Read more →RMDNatural ways to achieve better sleep
The article discusses various natural methods to improve sleep quality, including the use of essential oils, herbal teas, and sleep-promoting foods. It emphasizes the importance of mindfulness and exercise in achieving better sleep hygiene. While the effectiveness of these remedies is still being researched, they may contribute positively to overall health and sleep quality.
Read more →RMDNavigating the effects of daylight saving time
The article discusses the impact of daylight saving time (DST) on sleep patterns, emphasizing that while the fall transition may seem beneficial, it can disrupt sleep for many. Experts suggest practical tips for adjusting to the time change, such as gradual shifts in sleep times and maximizing sunlight exposure. Overall, the article aims to help readers navigate the challenges posed by DST.
Read more →RMDDo natural sleep aids really work?
Natural sleep aids are increasingly popular, especially among women and younger individuals. While some remedies like melatonin and yoga show promise, the effectiveness of many natural options remains inconclusive. Concerns about conventional sleep aids have led to a rise in interest for alternatives, but users should be cautious due to potential risks and lack of regulation.
Read more →RMDCan sleep apnea cause a stroke? Risk factors
The article discusses the significant link between sleep apnea and stroke, emphasizing that even mild cases can increase stroke risk. It explains how sleep apnea leads to reduced oxygen levels during sleep and highlights the severe health consequences of untreated sleep apnea, including stroke and other serious conditions. The article stresses the importance of addressing sleep apnea to mitigate these risks.
Read more →RMDCan sleep apnea cause morning headaches?
The article discusses the connection between sleep apnea and morning headaches. It explains that sleep apnea can block airways during sleep, reducing oxygen to the brain and leading to headaches. The article emphasizes the importance of consulting a doctor for diagnosis and treatment options, which may include therapy and lifestyle changes.
Read more →RMDDoes sleep apnea cause memory loss?
The article discusses the significant impact of sleep on memory, particularly in relation to sleep apnea. It explains that sleep apnea causes interruptions in breathing, leading to frequent awakenings that hinder the ability to achieve deep sleep. This disruption can impair memory retention and overall cognitive function. The importance of quality sleep for both physical and mental health is emphasized.
Read more →RMDDoes sleep apnea cause diabetes?
The article discusses the relationship between sleep apnea and diabetes, emphasizing that both conditions often occur together and can lead to serious health risks. It explains how sleep apnea can cause insulin resistance and glucose intolerance, increasing the risk of diabetes. The article also highlights the importance of recognizing symptoms and taking proactive measures, such as consulting a doctor and taking a symptom quiz.
Read more →RMDDoes sleep apnea affect blood pressure?
The article discusses the significant impact of sleep apnea on blood pressure, emphasizing that it can prevent normal blood pressure drops during sleep. This condition can lead to high blood pressure and increase the risk of heart-related issues. It encourages individuals to recognize symptoms and seek medical advice if necessary.
Read more →RMDThe sleep gap: How age, gender, and daily habits shape our nightly rest
The article discusses how various factors such as age, gender, and lifestyle impact sleep quality. A recent survey reveals significant sleep disparities, particularly among women and different generations. It emphasizes the importance of personalized approaches to improve sleep and highlights common sleep-related issues. The article also suggests consulting a doctor for persistent sleep problems.
Read more →RMDDoes insurance cover sleep apnea therapy?
The article discusses insurance coverage for sleep apnea therapy, confirming that most providers cover treatments like CPAP. Coverage may depend on the specific insurance policy, geographic location, and treatment prescribed. It emphasizes the importance of contacting your insurance provider for personalized information. The article also highlights that oral appliances are generally covered under medical insurance.
Read more →RMDDifferent types of CPAP masks and which to choose
The article discusses various types of CPAP masks available for sleep apnea patients, emphasizing the importance of comfort and fit in effective therapy. It outlines three main types: full face masks, nasal masks, and nasal pillow masks, each with unique advantages. The choice of mask can significantly impact treatment adherence and overall sleep quality.
Read more →RMDDiagnosed with sleep apnea? What’s next?
The article discusses the diagnosis of sleep apnea, highlighting that one in five Americans is affected. It emphasizes the importance of treatment options, particularly CPAP therapy, which is the most commonly prescribed. The article also reassures patients about the safety and effectiveness of CPAP therapy while addressing common concerns about using a mask.
Read more →RMDDiabetes and sleep apnea
The article discusses the strong association between diabetes and sleep apnea, noting that nearly half of type 2 diabetes patients also have sleep apnea. It emphasizes the importance of awareness and prevention, suggesting that individuals with one condition should be evaluated for the other. The medical community continues to explore the connection, although the exact cause remains unclear.
Read more →RMDDepression and sleep problems: Where sleep apnea fits in
The article discusses the complex relationship between depression and sleep disorders, particularly obstructive sleep apnea (OSA). Recent studies indicate that treating insomnia alongside depression can significantly improve outcomes. Additionally, continuous positive airway pressure (CPAP) therapy for sleep apnea has been shown to alleviate depressive symptoms. This highlights the importance of addressing sleep issues in treating depression.
Read more →RMDDaytime sleepiness: Is it a sign of sleep apnea?
Daytime sleepiness is a common symptom of obstructive sleep apnea (OSA), prompting individuals to seek diagnosis. While occasional sleepiness is normal, persistent drowsiness may indicate a need for a sleep test. Untreated OSA can lead to severe health issues, but there are effective treatments available, including CPAP therapy and oral appliances.
Read more →RMDCPAP travel tips: Flying with your CPAP machine
The article provides essential tips for travelers using CPAP machines, emphasizing the importance of preparation before flying. Key recommendations include packing necessary documentation, choosing seats with power access, and understanding TSA regulations. The article aims to ensure that individuals with sleep apnea can travel comfortably and safely without interrupting their treatment.
Read more →RMDWhat is the lifespan of a Resmed CPAP machine?
The lifespan of a Resmed CPAP machine is about five years, but components like masks require more frequent replacements. Regularly replacing CPAP supplies is crucial for effective sleep apnea therapy. Resmed offers a replacement guide and programs to assist users in maintaining their equipment. Health insurers often cover these replacements, enhancing therapy consistency.
Read more →RMDWhat is PAP therapy and how does it work?
PAP therapy is designed to prevent sleep apnea by delivering pressurized air through a device that keeps the airway open. The most common type is CPAP, which provides a continuous stream of air. Selecting the right device involves considering factors like brand, size, and comfort features. Consulting a healthcare provider is recommended for personalized treatment.
Read more →RMDAirFit F20: How to measure your ideal mask size
The article provides guidance on how to measure for the ideal size of the AirFit F20 CPAP mask from home. It details two methods: measuring with a ruler or tape measure, and using a printable sizing template. The article emphasizes the importance of a proper fit for successful CPAP therapy and encourages users to consult with professionals if issues persist.
Read more →RMD5 tips for getting through the holidays with sleep apnea
The article offers five essential tips for individuals with sleep apnea to navigate the holiday season effectively. Key recommendations include packing extra CPAP supplies, preparing for unfamiliar sleeping environments, avoiding certain foods, managing family stress, and ensuring smooth travel with CPAP equipment. These strategies aim to enhance comfort and minimize disruptions during festive gatherings.
Read more →RMDCPAP for COPD (and sleep apnea)
The article discusses the use of CPAP therapy for treating Chronic Obstructive Pulmonary Disease (COPD) and its connection to sleep apnea. It highlights that CPAP can improve breathing in COPD patients and is supported by clinical studies. Additionally, it notes the limited overlap between COPD and sleep apnea, emphasizing the benefits of CPAP in managing COPD symptoms.
Read more →RMDCPAP equipment – resources for your patients
The article provides healthcare professionals with curated resources to assist patients dealing with sleep apnea, particularly in the context of ongoing COVID-19 concerns. It includes guidance on cleaning CPAP equipment, accessing product manuals, and shopping for supplies online. The resources aim to enhance patient comfort and compliance with therapy.
Read more →RMDCPAP batteries and adaptors
The article discusses the benefits of using external batteries and adapters for CPAP therapy, particularly for travel. It highlights the Resmed Power Station II as a reliable option for powering CPAP devices without access to outlets. Additionally, it mentions the convenience of the Resmed AirMini for users on the go.
Read more →RMDCPAP and summer allergies
The article discusses the importance of using humidification with CPAP machines during summer allergies. It explains how humidification helps ease nasal congestion and inflammation caused by allergens, making CPAP use more effective. Additionally, it highlights potential issues with pillows masks for users with a deviated septum and suggests consulting with a doctor for optimal mask choices.
Read more →RMDCPAP air travel: What you should know
The article discusses the increasing acceptance of CPAP machines for air travel, highlighting TSA's supportive stance on bringing these devices aboard flights. It outlines the procedures for carrying CPAP equipment through security, including the need for X-ray screening and potential additional tests. The piece emphasizes the importance of keeping CPAP machines as carry-on luggage to avoid issues with lost baggage.
Read more →RMDCOPD treatment and Sleep apnea: NIV therapy
The article discusses the benefits of non-invasive ventilation (NIV) therapy for patients with chronic obstructive pulmonary disorder (COPD) and obstructive sleep apnea. Resmed's VPAP COPD machine offers features designed for comfort and ease of use. NIV therapy not only improves breathing but also enhances quality of life and reduces hospitalization risks for COPD patients.
Read more →RMDHow to get used to a CPAP machine
The article provides practical tips for individuals starting CPAP therapy for sleep apnea. It emphasizes the importance of gradually acclimating to the CPAP mask and machine, suggesting daytime practice and incremental use during sleep. The article also highlights the role of family support in improving adherence to treatment and encourages users to be patient during the adjustment period.
Read more →RMDCPAP mask leaks: Causes & how to fix them
The article addresses common issues with CPAP mask leaks, highlighting causes such as poor fit, inadequate cleaning, and mouth leaks. It emphasizes the importance of proper fitting and maintenance to enhance user experience. The article reassures readers that there are various mask options available to suit individual needs. It also encourages consultation with healthcare providers for tailored solutions.
Read more →RMDCommon complaint: CPAP dry mouth
The article discusses the common issue of dry mouth experienced by CPAP users, affecting about 40% of patients. It outlines three primary causes: medications or conditions, non-heated air, and severe mask leaks. Solutions include using a heated humidifier and ensuring a proper mask fit. The article emphasizes the importance of consulting a doctor for personalized advice.
Read more →RMDClimateLineAir and CPAP Rainout
The article discusses the ClimateLineAir heated tube designed for Resmed Air10 CPAP machines, which helps prevent CPAP rainout by maintaining the temperature of humidified air. This innovation aims to enhance user comfort and improve sleep quality, allowing for a more restful night. The heated tube is easy to use and integrates with the Air10's humidification system.
Read more →RMDCheyne-Stokes treatment: Overview of treating Cheyne-Stokes breathing
The article discusses treatment options for Cheyne-Stokes breathing, a condition often linked to heart failure and characterized by abnormal breathing patterns. It outlines five main treatment categories, including intensive heart failure management, respiratory stimulants, oxygen therapy, and CPAP. While some treatments show promise, concerns about their effectiveness and potential risks are noted.
Read more →RMDCentral sleep apnea treatment options
The article discusses treatment options for central sleep apnea (CSA), which differs from obstructive sleep apnea due to its neurological causes. Initial treatments often include lifestyle changes and the use of breathing devices. If these are ineffective, addressing underlying conditions may be necessary. Notably, some cases of CSA can resolve on their own.
Read more →RMDCentral sleep apnea symptoms
The article discusses the symptoms of central sleep apnea (CSA) and how they differ from those of obstructive sleep apnea (OSA). It outlines common symptoms such as loud snoring, daytime drowsiness, and chronic fatigue. Unique symptoms specific to CSA include changes in voice and difficulty swallowing. The article encourages readers to consult a doctor if they experience these symptoms.
Read more →RMDCentral sleep apnea causes
The article discusses the various causes of central sleep apnea (CSA), differentiating it from obstructive sleep apnea (OSA). It outlines five major types of CSA causes, including Cheyne-Stokes respiration, drug-induced factors, high altitudes, complex sleep apnea, and idiopathic CSA. The article emphasizes the complexity of CSA and the need for further exploration of its symptoms.
Read more →RMDWhat is COPD? Symptoms, causes and facts
Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of death globally, affecting millions. It is primarily caused by tobacco smoke and can be linked to sleep apnea, increasing health risks. Awareness and early detection are crucial, as many individuals remain undiagnosed. Treatment options exist, but no cure is available.
Read more →RMDCan exercise improve your sleep apnea?
The article discusses the positive impact of exercise and weight loss on obstructive sleep apnea (OSA). Studies indicate that losing weight can reduce sleep apnea symptoms, with a 10% weight loss correlating to a 26% decrease in apnea-hypopnea index. Additionally, myofunctional therapy exercises may further improve airway function. The article provides practical tips for integrating exercise into daily life.
Read more →RMDCan babies have sleep apnea? What to know
The article discusses the occurrence of sleep apnea in babies, categorizing it into apnea of infancy and apnea of prematurity. It emphasizes the differences in treatment and symptoms compared to adults. Parents are advised to consult a pediatric sleep specialist if their baby shows signs of sleep apnea. The blog promises to explore the two main types of sleep apnea in babies in future posts.
Read more →RMDCheyne-Stokes breathing: Definition & how to treat
Cheyne-Stokes respiration (CSR) is an abnormal breathing pattern often linked to central sleep apnea and other serious conditions like congestive heart failure. It features cycles of increasing and decreasing breathing, leading to periods of apnea. Understanding CSR is crucial for those experiencing sleep apnea symptoms, as it can coexist with obstructive sleep apnea. Consulting a doctor is advised for proper diagnosis.
Read more →RMDWhat is central sleep apnea? A look at the central sleep apnea definition
The article introduces central sleep apnea (CSA), highlighting its definition and differences from obstructive sleep apnea. CSA is characterized by a lack of respiratory effort during sleep, unlike obstructive sleep apnea, which involves physical blockage. The article emphasizes the importance of consulting healthcare professionals for accurate diagnosis and treatment options.
Read more →RMDCamping with CPAP: Solutions and helpful tips
Camping with CPAP therapy is now more feasible due to advancements in lightweight equipment and portable power solutions. Users can continue their sleep apnea therapy even in remote locations, as many modern CPAP machines, like those from Resmed, are designed for travel. Options for powering CPAP devices include using vehicle batteries or portable power sources, ensuring therapy can be maintained while enjoying the outdoors.
Read more →RMDYour top 6 AirMini questions answered
The article addresses common questions regarding the Resmed AirMini, the smallest sleep apnea machine. It covers its size, pricing, insurance coverage, and compatibility with CPAP masks. Additionally, it highlights the AirMini's humidification options and travel accessories. Overall, it provides essential information for potential users of the AirMini.
Read more →RMDYour sleep apnea test: What to expect
The article discusses the process of undergoing a sleep apnea test, detailing both in-lab and at-home testing options. It emphasizes the importance of consulting a doctor if experiencing symptoms of sleep apnea. The article also compares the costs of both testing methods and notes insurance considerations for coverage.
Read more →RMDYoung and restless: My CPAP story
Jonathan Trapse shares his journey with obstructive sleep apnea (OSA) and the importance of CPAP treatment. Diagnosed in college, he initially struggled with embarrassment and equipment adjustment. Over time, he experienced significant improvements in energy and mood, highlighting the need for awareness about sleep apnea and its treatment. His story serves as a reminder that OSA can affect anyone, regardless of age or size.
Read more →RMDCPAP humidifier: What it is, history & benefits
The article discusses the function and benefits of CPAP humidifiers in treating sleep apnea. It highlights the history of CPAP humidification, noting advancements from passive to heated humidification. The article also addresses common side effects and offers tips to optimize the use of humidifiers for better patient comfort.
Read more →RMDWhy does sleep apnea cause weight gain?
The article discusses how sleep apnea can lead to weight gain due to fatigue affecting exercise motivation and appetite regulation. Lack of sleep disrupts hormone levels, increasing hunger and cravings for unhealthy foods. Additionally, weight gain can worsen sleep apnea symptoms, creating a cycle of health issues. CPAP therapy is suggested as a potential treatment for better sleep quality.
Read more →RMDWhy does sleep apnea cause fatigue?
The article discusses how sleep apnea disrupts sleep, preventing individuals from achieving deep, restorative stages of sleep. It explains that both obstructive and central sleep apnea can lead to frequent awakenings, resulting in fatigue and a lack of energy. The piece emphasizes the serious health risks associated with untreated sleep apnea, including heart disease and diabetes.
Read more →RMDWhy does my apnea–hypopnea index (AHI) change?
The article explains the apnea-hypopnea index (AHI) and its significance in monitoring sleep apnea treatment. It highlights that AHI can fluctuate due to various factors, including mask fit and external substances. While minor variations are normal, significant increases should be reported to a healthcare provider. The article also suggests practical solutions for managing AHI effectively.
Read more →RMDWhy can’t I sleep? An interview with Dr. Harrington
In an interview with Dr. Carmel Harrington, various causes of sleep problems are discussed, including poor sleep habits and underlying issues like depression and anxiety. The emotional and physical consequences of sleep deprivation are highlighted, such as mood disturbances and increased accident risk. Dr. Harrington also points out the long-term health risks associated with chronic sleeplessness, including metabolic diseases.
Read more →RMDWho treats sleep apnea? Sleep apnea doctors
The article discusses the importance of self-education and communication with doctors for individuals diagnosed with sleep apnea. It outlines the process of getting diagnosed, including sleep studies that can be conducted at home or in a clinic. After diagnosis, collaboration with doctors and equipment providers is essential for effective treatment.
Read more →RMDWhen to replace CPAP supplies
The article emphasizes the importance of regularly replacing CPAP supplies to ensure effective sleep apnea therapy. It provides a detailed guideline on when to replace various components, such as mask cushions and filters. Additionally, it highlights the coverage of these replacements by Medicare and private insurers, and introduces a resupply program to assist users in managing their supply needs.
Read more →RMDWhat to do if your mask doesn’t fit right or leaks
The article discusses how to address issues with mask fit and comfort, particularly for those using CPAP masks. It emphasizes the importance of proper adjustment, cleaning, and possibly consulting a healthcare provider if problems persist. Additionally, it highlights the potential risks of using ozone devices with Resmed products.
Read more →RMDCaffeine and sleep apnea: What’s the connection?
The article explores the relationship between caffeine and sleep apnea, highlighting that while caffeine is often viewed negatively in relation to sleep, some studies suggest it may actually benefit patients with sleep apnea. Research indicates that higher caffeine intake can improve cognitive performance and reduce cognitive impairment in these patients. Additionally, caffeine is used in treating premature infants to help with breathing issues during sleep.
Read more →RMDBill’s story: Easy travel with the world’s smallest CPAP
Bill shares his experience with the Resmed AirMini, the world's smallest CPAP machine, which has made traveling easier for him. He highlights its portability, effective features, and shares practical tips for using the device while traveling. The AirMini is lightweight and designed for convenience, making it ideal for frequent travelers.
Read more →RMDBest sleep apps for 2019
The article reviews various sleep apps that can enhance sleep quality and overall health. It highlights apps like Couch to 5K for exercise, Insight Timer for meditation, and myAir for CPAP users. Each app is described in terms of functionality and its potential benefits for improving sleep. The article emphasizes the importance of technology in managing sleep health.
Read more →RMDBenefits of sleep apnea treatment may include looking better
A study from the University of Michigan Health System reveals that sleep apnea treatment may enhance appearance, making individuals look healthier and more youthful. This research is the first to formally assess the impact of sleep apnea therapy on personal appearance. The findings suggest that consistent treatment can improve alertness and attractiveness, potentially encouraging patients to adhere to their therapy.
Read more →RMDAvoid CPAP rainout
The article discusses CPAP rainout, a common issue where cooled air in the tubing condenses into water, causing discomfort. It offers solutions such as using heated tubing and adjusting humidifier settings to prevent this problem. Advanced CPAP technologies that automatically adjust temperature and humidity are also highlighted as beneficial.
Read more →RMDSleep apnea in premature babies & preemies
Apnea of prematurity (AOP) is a common condition in premature infants, characterized by episodes of stopped breathing. It typically resolves as the infant matures, but uncertainties remain regarding treatment efficacy and long-term effects. Pediatricians are concerned about the implications of untreated apnea, emphasizing the need for immediate intervention in NICU settings.
Read more →RMDAnxiety and sleep apnea: The sleep/health connection
The article explores the significant connection between anxiety and sleep apnea, highlighting that many individuals with sleep disorders also experience anxiety. Research indicates that while one condition does not necessarily cause the other, they often coexist. The findings suggest that improving sleep quality may help reduce anxiety levels, providing a potential pathway for treatment.
Read more →RMDA look at the best sleep aid for children
The article discusses the use of sleep aids for children, focusing on melatonin and media habits. While melatonin is commonly prescribed and considered safe under supervision, concerns about its overuse are rising. The article emphasizes that natural solutions and healthy sleep habits are preferable to medication. It highlights the negative effects of media on sleep quality.
Read more →RMDAllergies and sleep apnea: How are they connected?
The article discusses the connection between allergies and sleep apnea, explaining how nasal congestion from allergies can lead to obstructive sleep apnea (OSA). It notes that while allergies may not directly cause sleep apnea, they can exacerbate its symptoms. The article also highlights the importance of effective CPAP therapy for patients with both conditions and suggests consulting healthcare providers for tailored solutions.
Read more →RMDAlcohol and sleep apnea: A St. Patrick’s Day report
The article explores the relationship between alcohol consumption and sleep apnea, particularly in the context of St. Patrick's Day celebrations. It emphasizes that while moderate drinking is generally acceptable, heavy drinking can exacerbate sleep apnea symptoms. Medical professionals advise against alcohol consumption before bedtime and recommend consulting a doctor if alcohol use is suspected to contribute to sleep issues.
Read more →RMDAirline CPAP policies
The article discusses the importance of airline policies regarding traveling with CPAP machines. It emphasizes that passengers should inform their airline at least two weeks before their flight about their need for a CPAP device. A list of major airlines is provided for passengers to check specific policies. The article aims to facilitate a restful flight for those who require such medical devices.
Read more →RMDResMed Announces Participation in the UBS Global Healthcare Conference
ResMed announced that its CEO Mick Farrell and CMO Dr. Carlos Nunez will participate in a fireside chat at the UBS Global Healthcare Conference on November 12, 2024. This engagement provides an opportunity for ResMed to showcase its innovative healthcare solutions. The conference will be held at the Terranea Resort Hotel in California and will include a live, audio-only webcast. ResMed continues to emphasize its mission to improve the quality of life for individuals with chronic diseases through its digital health technologies and cloud-connected devices.
Read more →RMDAirFit F30: A modern take on the full face mask
The Resmed AirFit F30 is a modern full face mask designed for CPAP users who breathe through their mouth during sleep. It features a smaller design that minimizes facial contact and reduces red marks. The mask incorporates QuietAir technology for quieter operation and is preferred by many users for its comfort and usability compared to other masks.
Read more →RMDResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025
ResMed Inc. reported its financial results for the first quarter of FY 2025, showing an 11% increase in revenue and a 34% rise in operating profit compared to the prior year. The company announced a strong operating cash flow of $326 million and celebrated milestones, including its 35 years of innovation. Additionally, it introduced a new product, the AirTouch N30i mask, as part of its ongoing strategy to enhance patient care and drive growth. ResMed also outlined its 2030 strategy to further its mission in improving global health outcomes.
Read more →RMDFor investors For media +1 858-836-5000 +1 619-510-1281 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2025 Year-over-year revenue grows 11%, operating pro
ResMed Inc. reported strong financial results for the first quarter of fiscal year 2025, showing an 11% increase in revenue compared to the previous year. Operating profit surged by 34% alongside a notable rise in net income, which increased by 42%. The company's focus on digital health and operational excellence supports its commitment to improving global health outcomes with innovative solutions. ResMed also declared a quarterly cash dividend, reflecting their financial stability and return on investment for shareholders.
Read more →RMDResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024
ResMed (NYSE: RMD, ASX: RMD) has announced it will release its financial results for the first quarter of fiscal year 2025 on October 24, 2024, after market closing. A webcast will follow to discuss these results and other relevant information. The company continues to emphasize its focus on innovative healthcare solutions and digital technologies aimed at improving patient outcomes and reducing healthcare costs. A replay of the webcast will be available on their website shortly after the live event.
Read more →RMDResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
ResMed has unveiled new technologies aimed at enhancing sleep health for apnea patients, including the integration of its myAir app with smartwatches. A new Generative AI sleep health assistant named Dawn will provide personalized guidance and support for users. Additionally, ResMed introduced a line of travel gear designed to facilitate CPAP therapy while traveling. These innovations are part of ResMed's ongoing commitment to improve user engagement and therapy compliance for better health outcomes.
Read more →RMDResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
ResMed has launched the AirTouch N30i, its first fabric CPAP mask aimed at enhancing user comfort for sleep apnea patients. This innovative mask features a soft, moisture-wicking design and provides a natural fit, which 92.6% of experienced users preferred for long-term use. The AirTouch N30i is poised to set new standards in CPAP therapy with its appealing aesthetics and advanced comfort technologies. The mask is scheduled for release in the U.S. on October 28, 2024.
Read more →RMDResMed Unveils 2030 Strategy to Drive Growth, Profitability, and Shareholder Returns
ResMed has introduced its 2030 Strategy to enhance growth, profitability, and shareholder returns, alongside an updated five-year financial outlook. The company aims to assist over 500 million individuals in achieving optimal health and plans to invest significantly in innovation to strengthen its market position. Key aspects of the strategy include focusing on enhancing its core sleep apnea franchise, expanding into adjacent markets, and integrating digital health solutions. The leadership emphasizes a commitment to improving patient experiences and operational excellence to meet projected financial goals.
Read more →RMDWearable tech’s role in the future of sleep health
Wearable technology is increasingly recognized for its role in enhancing sleep health. A recent survey indicates that 36% of respondents track their sleep, with Gen Z showing the highest interest. The data from wearables can guide users in improving their sleep habits, although caution is advised regarding device comfort and accuracy. Users are encouraged to consult healthcare providers if sleep data indicates potential disorders.
Read more →RMDResMed to Host Its 2024 Investor Day on September 30, 2024, at the New York Stock Exchange
ResMed will host its 2024 Investor Day on September 30, 2024, at the New York Stock Exchange. The event is expected to outline the company's strategic goals for 2030 and will be accessible both in-person and through a live webcast. Details for attending the event and accessing the archived webcast will be made available soon. ResMed focuses on innovative healthcare solutions for chronic diseases, emphasizing improved patient care and cost reduction.
Read more →RMDResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference
ResMed has announced that Chairman and CEO Mick Farrell, along with CMO Dr. Carlos Nunez, will participate in a fireside chat at the upcoming Morgan Stanley 22nd Annual Global Healthcare Conference. Scheduled for September 4, 2024, the event will take place at the New York Marriott Marquis, with live access available via a webcast. ResMed aims to showcase its innovative solutions in healthcare during this high-profile event, furthering its outreach and engagement in the healthcare community.
Read more →RMDFor investors For media +1 858.836.5971 +1 619.510.1281 investorrelations@resmed.com news@resmed.com ResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader Christopher DelOref
ResMed has announced the expansion of its board of directors to 11 members with the appointment of Christopher DelOrefice. Effective immediately, DelOrefice, who is the CFO of Becton, Dickinson and Company, will also serve on ResMed's audit committee. His extensive experience in finance and global operations management is expected to augment ResMed's strategic goals. He will stand for re-election at the annual meeting scheduled for November 21, 2024.
Read more →RMDResMed Expands its Board of Directors and Appoints Healthcare Executive and Seasoned Finance Leader Christopher DelOrefice to its Board
ResMed has expanded its board of directors to include Christopher DelOrefice, effective immediately. DelOrefice, currently CFO of Becton, Dickinson and Company, brings over 30 years of finance and strategic expertise to the company. He will serve on the board's audit committee and stand for re-election at the annual meeting on November 21, 2024. The addition is seen as a positive move to strengthen ResMed's leadership in the healthcare industry.
Read more →RMDResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2024
ResMed Inc. reported a strong performance in its fourth quarter of fiscal year 2024, with revenues increasing by 9% to $1.2 billion compared to the prior year. Operating profit rose by 38%, and the company announced a 10% increase in its quarterly dividend to $0.53 per share. The company also highlighted increased demand for its devices and software solutions, as well as a commitment to continue growth in the underpenetrated sleep health market. An Investor Day is scheduled for September 30, 2024, where further insights into the company's strategy will be shared.
Read more →RMDFor investors For media +1 858-836-5000 +1 619-510-1281 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2024 Year-over-year revenue grows 9%, operating pro
ResMed Inc. announced its fourth quarter results for fiscal year 2024, showcasing a 9% increase in revenue compared to the previous year, totaling $1.22 billion. The company's gross margin improved to 58.5%, driven by operational efficiencies and a surge in customer demand for its products. Notably, net income rose by 27% to $292.2 million, reflecting significant profitability growth. Additionally, ResMed declared a quarterly cash dividend of $0.53 per share, further emphasizing its commitment to returning value to shareholders.
Read more →RMDResMed to Report Fourth Quarter Fiscal 2024 Earnings on August 1, 2024
ResMed announced that it will report its financial and operational results for the fourth quarter of fiscal year 2024 on August 1, 2024. After the results are released, management will host a webcast to discuss key insights and other forward-looking information. The earnings call will be accessible through a provided webcast link, with a replay available shortly after. ResMed emphasizes its role in delivering innovative healthcare solutions, particularly for chronic diseases.
Read more →RMDResMed Announces Participation in the RBCCM Global Healthcare Conference
ResMed (NYSE: RMD) will be represented by Dr. Carlos Nunez and Amy Wakeham during a fireside chat at the 2024 RBCCM Global Healthcare Conference on May 14, 2024. The event aims to discuss ResMed's innovative healthcare solutions and technologies for managing chronic diseases such as sleep apnea and COPD. Interested parties can access the live webcast and subsequent replay through ResMed's investor relations platform.
Read more →RMDRazer VR accessories with Resmed technology
Kontor, a Resmed company, has partnered with Razer to launch two new accessories for the Meta Quest 3: the Razer Facial Interface and the Razer Adjustable Head Strap System. These products aim to enhance comfort and usability for gamers, featuring hypoallergenic materials and a design that accommodates diverse head shapes. Both accessories are now available for purchase in the US, Canada, and Europe.
Read more →RMDFor investors For media +1 858-836-5000 +1 619-510-1281 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024 Year-over-year revenue grows 7%, operating prof
ResMed Inc. reported its financial results for the third quarter of fiscal year 2024, showing a 7% increase in revenue compared to the previous year. The growth is attributed to high demand for its products and software solutions, with significant increases in operating profit and net income. The company also announced a quarterly cash dividend and continues to focus on innovation in its product offerings. Overall, the results reflect a strong performance for ResMed in the current fiscal year.
Read more →RMDResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024
ResMed Inc. reported strong financial results for the third quarter of fiscal year 2024, with revenue rising by 7% to $1.2 billion and a 25% increase in operating profit. The company highlighted robust demand for its sleep devices and masks, contributing to improved operating margins and profitability. Notably, ResMed introduced new products like the AirCurve11 non-invasive ventilators and the AirFit F40 mask. The company's diluted earnings per share rose to $2.04, reflecting successful capital management and operational efficiencies.
Read more →RMDResMed to Report Third Quarter Fiscal 2024 Earnings on April 25, 2024
ResMed announced its plans to release financial and operational results for the third quarter of fiscal 2024 on April 25, 2024. The announcement follows a typical earnings release schedule, with management set to host a webcast to discuss these results. The webcast will also provide additional forward-looking information related to the company's performance and strategies. ResMed continues to focus on solutions that improve quality of life for patients with chronic diseases.
Read more →RMDResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis
ResMed's 2024 Global Sleep Survey revealed a widespread sleep crisis affecting many individuals worldwide, with nearly 40% experiencing poor sleep. The survey, which included 36,000 respondents across 17 markets, highlighted that personal anxiety, insomnia, and breathing difficulties are significant contributors to sleep issues. Despite the challenges, the survey showed that a good night's sleep brought benefits such as improved concentration, productivity, and mental health awareness among the participants. There is an increasing trend of individuals actively tracking their sleep patterns to enhance sleep quality.
Read more →RMDResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions about Care, Deliver Personalized Support, and Drive Positive Therapy Outcomes for Patients with Sleep Apnea
ResMed has launched its new AirCurve 11 series bilevel devices, designed to improve therapy for sleep apnea patients. These devices utilize advanced technology to assist healthcare providers in delivering personalized care, enhancing patient comfort, and promoting adherence to therapy. Key features include integrated digital health applications that allow for real-time monitoring, patient engagement, and automated data transmission to improve therapy outcomes. The AirCurve 11 series aims to provide a significant upgrade in sleep apnea treatment options, focusing on patient-centric solutions in various global markets.
Read more →RMDFor investors For media +1 858-836-5000 +1 619-510-1281 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024 Year-over-year revenue grows 12%, operating pr
ResMed Inc. reported its financial results for the second quarter of fiscal year 2024, showcasing a 12% increase in revenue year-over-year, driven by strong growth in devices and software. Despite the impressive top-line growth, net income fell by 7%, reflecting added costs in operational areas. The company highlighted successful product launches and strategic acquisitions that enhance its market position. ResMed aims to enhance brand awareness and operational excellence as it strives to improve the lives of 250 million patients by 2025.
Read more →RMDResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2024
ResMed Inc. announced its financial results for the second quarter of fiscal year 2024, reporting a 12% increase in revenue year-over-year, totaling $1.2 billion. While the company experienced a 2% decrease in operating profit, its non-GAAP metrics reflected a 20% increase in profitability. The firm resumed its share repurchase program, acquiring $50 million worth of shares during the quarter. Additionally, ResMed is focusing on leading the growth in sleep and breathing health market with ongoing product innovations.
Read more →RMDResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024
ResMed announced it will release its financial and operational results for the second quarter of fiscal year 2024 on January 24, 2024, after market close. Following the release, a webcast will be hosted by management to discuss the results. ResMed highlights its role in pioneering innovative healthcare solutions and stresses its commitment to enhancing the quality of life for patients with chronic diseases through its digital health technologies.
Read more →RMDResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference
ResMed has announced that CEO Mick Farrell will present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024. The event will provide insights into the company's innovative solutions for treating chronic diseases. Attendees can access the presentation via a live audio-only webcast, with a replay available for 30 days afterward. ResMed emphasizes its mission to improve quality of life through digital health technologies and cloud-connected devices.
Read more →RMDResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical Devices
ResMed has announced a voluntary global field action to update guides for masks with magnets due to potential magnetic interference with medical implants. The updated safety instructions inform users about the contraindications related to the use of these masks. Although no permanent injuries or deaths have been reported, there have been five cases of serious harm associated with magnetic interference. Affected customers are being notified and provided with detailed guidance on how to ensure safety while using these products.
Read more →RMDResMed Secures Significant Victory in Patent Fight Against New York University
ResMed has achieved a significant legal victory in a patent infringement case against New York University. The United States Patent Trial and Appeals Board (PTAB) invalidated all claims from seven patents that NYU had asserted against ResMed's products, particularly the AutoSet and AutoRamp features of the AirSense 10 AutoSet flow generators. This ruling is a confirmation of ResMed's strategy to protect its intellectual property and underscores its long-term investment in research and development. Following the decision, ResMed's executives expressed their commitment to continue defending their innovations for the benefit of their patients.
Read more →RMDAI and XR: Redefining boundaries of reality
The article discusses the integration of artificial intelligence (AI) with extended reality (XR) technologies, highlighting how AI enhances XR experiences across various sectors. It covers the principles of AI that impact XR, such as machine learning and object recognition, and outlines the applications of AI-powered XR in training, gaming, and entertainment. Additionally, the article addresses challenges like data privacy and processing power limitations that need to be overcome for broader adoption.
Read more →RMDResMed Adopts New Operating Model to Accelerate Long-term Growth
ResMed has announced a new operating model aimed at accelerating long-term growth, which involves appointing dedicated leaders for Product, Revenue, and Marketing. Justin Leong, Katrin Pucknat, and Mike Fliss have been appointed to key executive positions. The company's CEO, Mick Farrell, emphasizes the importance of increased product development velocity and brand engagement to enhance the company's position in digital health for respiratory medicine. Notably, Rob Douglas, the current COO, will retire on January 1, 2024, marking a significant transition in leadership.
Read more →RMDFor media +1 858-836-6798 news@resmed.com For investors +1 858.836.5000 investorrelations@resmed.com ResMed Adopts New Operating Model to Accelerate Long-term Growth - Justin Leong appointed Chief Product Officer, effect
ResMed has adopted a new operating model designed to accelerate long-term growth by emphasizing product development and customer engagement. This model introduces dedicated leadership roles in Product, Revenue, and Marketing, aiming to enhance effectiveness across these areas. Additionally, the company announced the retirement of Rob Douglas and the reorganization of several executive positions, reflecting a strategic shift towards becoming more product-led and customer-centric. CEO Mick Farrell expressed confidence that these changes will drive profitable growth and create increased value for stakeholders.
Read more →RMDResMed Inc. Announces Results for the First Quarter of Fiscal Year 2024
ResMed Inc. reported a 16% increase in revenue for the first quarter of fiscal year 2024, reaching $1.1 billion. The company noted a 5% increase in operating profit and a 10% rise in non-GAAP operating profit, despite a contraction in gross margins. CEO Mick Farrell highlighted strong demand for sleep and respiratory care products and the successful introduction of AI-driven software solutions. ResMed also announced plans to resume its share repurchase program, indicating confidence in future growth.
Read more →RMDFor investors For media +1 858-836-5000 +1 858-289-7272 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2024 Year-over-year revenue grows 16%, operating pro
ResMed Inc. reported a robust performance for the first quarter of fiscal 2024, achieving a 16% year-over-year revenue growth driven by increased global demand for its sleep and respiratory care solutions. The company also highlighted strong adoption of its AI-driven software products within their digital health ecosystem. However, the gross margin experienced a decline, and operational expenses have risen, which may pose concerns for investors amidst this otherwise positive growth trajectory.
Read more →RMDKontor earns the esteemed Good Design Award
Kontor has been awarded the Good Design Award for its Razer Adjustable Head Strap System and Facial Interface for Meta Quest 2. This recognition, announced on September 8, 2023, underscores the product's innovative design aimed at enhancing user comfort in virtual reality. The awards celebrate outstanding design across various disciplines and are highly regarded in Australia.
Read more →RMD▼ -5.5%on this newsshared move
What is mixed reality (MR)?
Mixed reality (MR) merges augmented reality (AR) and virtual reality (VR), allowing digital and physical elements to interact. It offers significant benefits across various industries, such as healthcare and automotive, by enhancing collaboration and productivity. As technology advances, MR is expected to become even more integrated into everyday life, providing unique immersive experiences.
Read more →RMDWhat is augmented reality (AR)?
Augmented reality (AR) is an immersive technology that overlays digital content onto the real world, accessed through devices like smart glasses and smartphones. Its applications span various industries, including education, healthcare, and automotive, enhancing user experiences and operational efficiency. The technology has evolved significantly since its inception in the late 1960s, with increasing adoption and innovation.
Read more →RMDResMed to Report First Quarter Fiscal 2024 Earnings on October 26, 2023
ResMed (NYSE: RMD) is set to announce its financial results for the first quarter of fiscal 2024 on October 26, 2023. After the release, a webcast will be held to discuss the results and any material forward-looking information. The webcast will be accessible via their investor relations website. ResMed emphasizes its commitment to innovative solutions for chronic diseases.
Read more →RMDWhat is virtual reality (VR)?
The article explores the evolution and capabilities of virtual reality (VR), highlighting its immersive nature through head-mounted displays. It discusses the historical development of VR, from early concepts to modern advancements, including the integration of artificial intelligence to enhance user experiences. The distinction between VR and augmented reality (AR) is also clarified, emphasizing their different approaches to reality.
Read more →RMDResMed Announces Participation in Upcoming Conferences
ResMed has announced its participation in two major upcoming healthcare conferences, with key executives leading discussions. CEO Mick Farrell and CFO Brett Sandercock will attend the Morgan Stanley 21st Annual Global Healthcare Conference on September 12, 2023, in New York City. Additionally, COO Rob Douglas and communications officer Amy Wakeham will participate in the Bank of America Global Healthcare Conference in London on September 14, 2023. These events emphasize ResMed's ongoing commitment to advancing healthcare solutions.
Read more →RMDThe differences between VR, AR, and MR
The article discusses the differences between virtual reality (VR), augmented reality (AR), and mixed reality (MR), collectively known as extended reality (XR). It highlights the unique characteristics and use cases of each technology across various industries, including manufacturing, real estate, healthcare, and tourism. The distinctions between these immersive technologies are essential for understanding their applications and benefits.
Read more →RMDFor investors For media +1 858-836-5000 +1 858-289-7272 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2023 Year-over-year revenue grows 23%, operating pr
ResMed Inc. reported strong financial results for the fourth quarter of fiscal year 2023, revealing a 23% increase in revenue compared to the previous year. The company attributed this growth to high demand for its cloud-connected devices and the expansion of its patient interface solutions. ResMed's investments in research and development also reflected a commitment to innovation. Additionally, the board declared a quarterly cash dividend, indicating ongoing confidence in its financial stability.
Read more →RMDResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2023
ResMed Inc. reported a significant revenue increase of 23% year-over-year for the fourth quarter of fiscal year 2023, amounting to $1.1 billion. The company also announced an increase in diluted earnings per share to $1.56 and a quarterly dividend of $0.48 per share. However, gross margins contracted due to unfavorable product mix and increased costs. Additionally, ResMed completed the acquisition of Somnoware to strengthen its diagnostic offerings amid strong demand for cloud-connected sleep devices.
Read more →RMDResMed to Report Fourth Quarter Fiscal 2023 Earnings on August 3, 2023
ResMed has announced it will release its fourth quarter fiscal 2023 earnings on August 3, 2023. The financial and operational results will be disclosed after the New York Stock Exchange closes, followed by a management-hosted webcast to discuss the outcomes. The earnings call will be accessible only through the provided webcast link, and a replay will be available shortly after the event. This release is part of ResMed's commitment to transparency and ongoing improvement in healthcare technology solutions.
Read more →RMDResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software
ResMed has announced its acquisition of Somnoware, a leader in digital sleep and respiratory care diagnostics software. This move aims to enhance ResMed's existing digital health landscape and streamline processes for physicians and sleep labs. The Somnoware platform will remain open and interoperable to allow for various testing solutions, improving the patient diagnosis and treatment journey. Financial terms of the acquisition were not disclosed, but ResMed intends to retain Somnoware's staff and integrate its offerings fully into its ecosystem.
Read more →RMDResMed Announces Participation in the Goldman Sachs 44th Annual Global Healthcare Conference
ResMed has announced that Rob Douglas, its president and COO, will participate in a fireside chat at the Goldman Sachs 44th Annual Global Healthcare Conference on June 12, 2023. The event will take place at the Waldorf Astoria Monarch Beach in Dana Point, CA, and will be accessible through a live audio-only webcast. Following the live presentation, a recording will be available for 180 days. This participation highlights ResMed's focus on innovative healthcare solutions and their role in chronic disease management.
Read more →RMDResMed Appoints Michael Rider its Next Global General Counsel, Dawn Haake its First Chief Quality Officer
Rider and Haake, both internal promotions, joined ResMed’s executive team on May 1 Rider, currently Senior Vice President, Deputy Global General Counsel will succeed retiring Chief Administrative Officer, Global General Counsel, and Secretary David Pendarvis on July 1 SAN DIEGO
Read more →RMDResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2023
Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, April 27, 2023 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended March 31, 2023. Third Quarter 2023 Hig
Read more →RMDFor investors +1 858-836-5000 investorrelations@resmed.com For media +1 858-836-6798 news@resmed.com ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2023 Year-over-year revenue grows 29%, operating pro
ResMed Inc. reported strong financial results for the third quarter of fiscal year 2023, with revenues growing by 29% year-over-year to $1.12 billion. Operating profit also saw an increase of 28%. The company highlighted a significant ramp-up in the production and delivery of its cloud-connected devices to meet customer demand. In addition, ResMed's efforts in expanding its software-as-a-service business and enhancing patient adherence were noted, further contributing to its positive growth trajectory.
Read more →RMDResMed to Report Third Quarter Fiscal 2023 Earnings on April 27, 2023
SAN DIEGO, April 06, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2023 on Thursday, April 27, 2023, after the New York Stock Exchange closes. Following the release,
Read more →RMDResMed Chief Administrative Officer and Global General Counsel to Retire
ResMed to conduct an internal search for a successor general counsel Amy Wakeham appointed Chief Communications and Investor Relations Officer, will join ResMed’s executive leadership team SAN DIEGO, March 30, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) announced toda
Read more →RMDFor media For investors news@resmed.com investorrelations@resmed.com +1 858.836.6798 +1 858.836.5000 ResMed Chief Administrative Officer and Global General Counsel to Retire ResMed to conduct an internal search for a suc
ResMed announced the retirement of David Pendarvis, Chief Administrative Officer and Global General Counsel, effective June 30, 2023. He will assist in a consulting role until December 31, 2023. The company plans to find a successor for Pendarvis’s roles through an internal search prior to his retirement. Amy Wakeham is appointed as the new Chief Communications and Investor Relations Officer, reflecting ResMed's focus on leadership continuity.
Read more →RMDResMed Announces Participation in the 2023 KeyBanc Life Sciences & MedTech Investor Forum
SAN DIEGO, March 15, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will join a fireside chat at the 2023 KeyBanc Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023, beginning at approximate
Read more →RMDResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep
81% of respondents experience one or more symptoms indicating poor sleep quality, despite 64% saying they’re satisfied with the quantity of their sleep Women and older generations are less satisfied with the quality and quantity of their sleep compared to the survey’s overall av
Read more →RMDResMed Announces Participation in the Oppenheimer 33rd Annual Healthcare Conference
SAN DIEGO, March 07, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will present at the Oppenheimer 33rd Annual Healthcare Conference on Monday, March 13, 2023, beginning at approximately 11:20 a.m. (Easte
Read more →RMDFor investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2023 Year-over-year re
ResMed Inc. announced its financial results for the second quarter of fiscal year 2023, highlighting significant revenue growth and successful acquisition of MEDIFOX DAN, which enhances its Software-as-a-Service ('SaaS') business. The company reported a revenue increase of 16% year-over-year, with a net income of $224.9 million. ResMed also achieved substantial progress in its mission to improve health outcomes for millions globally. Additionally, a quarterly dividend of $0.44 per share was declared.
Read more →RMDResMed Appoints Michael Farrell as Chair of its Board of Directors Peter Farrell to Become Chair Emeritus
SAN DIEGO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced ResMed’s board of directors has appointed chief executive officer Michael (“Mick”) Farrell as chair of the board, effective January 25, 2023. Mr. Farrell succeeds current chair Peter Farrell
Read more →RMDResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2023
Year-over-year revenue grows 16%, operating profit up 13%, non-GAAP operating profit up 14% Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX
Read more →RMDResMed to Report Second Quarter Fiscal 2023 Earnings on January 26, 2023
SAN DIEGO, Jan. 12, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2023 on Thursday, January 26, 2023, after the New York Stock Exchange closes. Following the releas
Read more →RMDResMed Announces Participation in the 41st Annual J.P. Morgan Healthcare Conference
SAN DIEGO, Jan. 02, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023, beginning at approximately 1:30 p.m. (Pacific Standard Ti
Read more →RMDResMed Completes Acquisition of MEDIFOX DAN, a German Leader in Out-of-Hospital Care Management Software Solutions
- Acquisition expands ResMed’s SaaS business to Germany, first non-U.S. market - Outpatient therapy services added to ResMed’s growing SaaS offering portfolio - Purchase price of €958.6 million (US$997.5 million); deal will be accretive to non-GAAP diluted earnings per share
Read more →RMDResMed Opens Manufacturing Centre in Singapore, Expanding Manufacturing Footprint to Support Growth, Development, and Production of Digital Health Solutions
New 270,000-square-foot (25,000-square-meter) facility in Tuas marks the next stage in ResMed’s more than decade-long presence in Singapore; will account for nearly 1,000 jobs across a variety of skill sets, contributing to the country’s fast-growing local health technology secto
Read more →RMDFor investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2023 Year-over-year rev
For investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2023 Year-over-year revenue grows 5%, operating profit up 5%, non-GAAP operat
Read more →RMDResMed Inc. Announces Results for the First Quarter of Fiscal Year 2023
Year-over-year revenue grows 5%, operating profit up 5%, non-GAAP operating profit up 4% Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Oct. 27, 2022 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX: R
Read more →RMDResMed to Report First Quarter Fiscal 2023 Earnings on October 27, 2022
SAN DIEGO, Oct. 13, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2023 on Thursday, October 27, 2022, after the New York Stock Exchange closes. Following the release
Read more →RMDResMed Announces Participation in the Bank of America Global Healthcare Conference
SAN DIEGO, Sept. 07, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the Bank of America Global Healthcare Conference on Wednesday, September 14, 2022, beginning at approximately 9
Read more →RMDResMed Announces Participation in the 20th Annual Morgan Stanley Global Healthcare Conference
SAN DIEGO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a fireside chat at the 20th Annual Morgan Stanley Global Healthcare Conference on Monday, September 12, 2022, beginni
Read more →RMDFor investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2022 Year-over-year re
For investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2022 Year-over-year revenue grows 4%, operating profit up 6%, non-GAAP opera
Read more →RMDResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2022
Year-over-year revenue grows 4%, operating profit up 6%, non-GAAP operating profit up 4% Quarterly dividend increases 5% to $0.44 per share Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Aug. 11, 202
Read more →RMDResMed Acquires Leipzig-based mementor with Insomnia Digital Health Solution somnio
Acquisition lays foundation to build ResMed’s digital sleep medicine portfolio in Germany somnio digital health application focused on improving sleep in patients with diagnosed insomnia, filling care gap and providing alternative to prevailing drug therapy mementor to be integ
Read more →RMDResMed to Report Fourth Quarter Fiscal 2022 Earnings on August 11, 2022
SAN DIEGO, July 14, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2022 on Thursday, August 11, 2022, after the New York Stock Exchange closes. Following the release
Read more →RMDFor media For investors Jayme Rubenstein Amy Wakeham +1 858.836.6798 +1 858.836.5000 news@resmed.com investorrelations@resmed.com ResMed Promotes Lucile Blaise to President, Sleep & Respiratory Care - Blaise is a medtech
For media For investors Jayme Rubenstein Amy Wakeham +1 858.836.6798 +1 858.836.5000 news@resmed.com investorrelations@resmed.com ResMed Promotes Lucile Blaise to President, Sleep & Respiratory Care SAN DIEGO, June 28, 2022 ResMed (NYSE: RMD, ASX: RMD) today announced the p
Read more →RMDResMed Promotes Lucile Blaise to President, Sleep & Respiratory Care
Blaise is a medtech industry thought leader with over 25 years’ experience A board member of MedTech Europe since 2020; President of the Snitem, France’s premier medtech association Promotion effective July 1 SAN DIEGO, June 28, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX:
Read more →RMDResMed to Acquire MEDIFOX DAN, a German Leader in Out-of-Hospital Software Solutions
Acquisition creates a global leader in out-of-hospital software solutions Accelerates ResMed’s SaaS strategy by extending ResMed’s position as a leading U.S. provider of SaaS solutions in out-of-hospital care settings into Germany MEDIFOX DAN will integrate into ResMed’s out-of
Read more →RMDFor media For media Jayme Rubenstein Laura Willig +1 858.836.6798 +49 51 21 / 28 29 1-808 news@resmed.com l.willig@medifoxdan.de For investors Amy Wakeham +1 858.836.5000 investorrelations@resmed.com ResMed to Acquire ME
For media For media Jayme Rubenstein Laura Willig +1 858.836.6798 +49 51 21 / 28 29 1-808 news@resmed.com l.willig@medifoxdan.de investorrelations@resmed.com ResMed to Acquire MEDIFOX DAN, a German Leader in Out-of-Hospital Software SAN DIEGO and HILDESHEIM, GERMA
Read more →RMDResMed Announces Participation in the 43rd Annual Goldman Sachs Global Healthcare Conference
SAN DIEGO, June 07, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the Goldman Sachs Global Healthcare Conference on Tuesday, June 14, 2022, beginning at approximately 1:20 p.m. (
Read more →RMDResMed Announces Participation in the 42nd Annual William Blair Growth Stock Conference
SAN DIEGO, June 01, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will present at the William Blair Growth Stock Conference on Wednesday, June 8, 2022, beginning at approximately 9:20 a.m. (Central Daylig
Read more →RMDResMed Announces Participation in the 38th Annual Bernstein Strategic Decisions Conference
SAN DIEGO, May 25, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the Bernstein Strategic Decisions Conference on Wednesday, June 1, 2022, beginning at approximately 1:30 p.m. (Ea
Read more →RMDResMed Announces Leadership Change
SAN DIEGO, May 05, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced that Jim Hollingshead, President, Sleep and Respiratory Care, has informed ResMed that he has accepted a new position and is leaving the company, effective immediately. Rob Douglas, President
Read more →RMDFor media For investors Jayme Rubenstein Amy Wakeham +1 858-836-6798 +1 858.836.5000 news@resmed.com investorrelations@resmed.com ResMed Announces Leadership Change
For media For investors Jayme Rubenstein Amy Wakeham +1 858-836-6798 +1 858.836.5000 news@resmed.com investorrelations@resmed.com ResMed Announces Leadership Change SAN DIEGO, May 5, 2022 ResMed (NYSE: RMD, ASX: RMD) today announced that Jim Hollingshead, President,
Read more →RMDResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2022
Year-over-year revenue grows 12%, operating profit up 5%, non-GAAP operating profit up 5% Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, April 28, 2022 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX:
Read more →RMDFor investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2022 Year-over-year rev
For investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2022 Year-over-year revenue grows 12%, operating profit up 5%, non-GAAP opera
Read more →RMDResMed Announces Participation in the 24th Annual Macquarie Australia Conference
SAN DIEGO, April 27, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Brett Sandercock, chief financial officer, will present virtually at the Macquarie Australia Conference on Tuesday, May 3, 2022, beginning at approximately 8:45 a.m. (Australian Eastern Sta
Read more →RMDResMed to Report Third Quarter Fiscal 2022 Earnings on April 28, 2022
SAN DIEGO, April 07, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2022 on Thursday, April 28, 2022, after the New York Stock Exchange closes. Following the release,
Read more →RMDResMed Announces Participation in the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum
SAN DIEGO, March 17, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum on Tuesday, March 22, 2022, beginni
Read more →RMDResMed’s Global Sleep Surveys Reveal What’s Keeping Us Up at Night; Aim to Bring Awareness to the State of Sleep Health for World Sleep Day
Surveys found pandemic-related stress and anxiety are the most cited reasons keeping people up at night Quality and quantity of sleep have benefitted from remote working, and many are concerned waking up will be difficult as they return to a physical workplace More than half of
Read more →RMDResMed Announces Participation in the Oppenheimer 32nd Annual Healthcare Conference
SAN DIEGO, March 10, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will present at the Oppenheimer 32nd Annual Healthcare Conference on Tuesday, March 15, 2022, beginning at approximately 1:20 p.m. (Easte
Read more →RMDResMed Announces Participation in the Citi Healthcare Conference
SAN DIEGO, Feb. 16, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the Citi Healthcare Conference on Wednesday, February 23, 2022, beginning at approximately 12:30 p.m. (E
Read more →RMDResMed Welcomes Urvashi Tyagi as New Chief Technology Officer
Tyagi brings over 25 years’ IT and leadership experience from ADP, American Express, Amazon, Microsoft, and IBM Current CTO and SaaS President Bobby Ghoshal now transitions to SaaS full-time SAN DIEGO, Feb. 01, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announc
Read more →RMDResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2022
Year-over-year revenue grows 12%, operating profit up 12%, non-GAAP operating profit up 5% Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Jan. 27, 2022 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX:
Read more →RMDFor investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2022 Year-over-year re
For investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2022 Note: A webcast of ResMed s conference call will be available at 4:30 p
Read more →RMDResMed to Report Second Quarter Fiscal 2022 Earnings on January 27, 2022
SAN DIEGO, Jan. 06, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2022 on Thursday, January 27, 2022, after the New York Stock Exchange closes. Following the releas
Read more →RMDResMed Announces Participation in the 40th Annual J.P. Morgan Healthcare Conference
SAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022, beginning at approximately 1:30 p.m. (Eastern Standard T
Read more →RMDResMed Announces Participation in the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference
SAN DIEGO, Dec. 30, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will present at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference on Thursday, January 6, 2022, beginning at approximately 4:00 p.m.
Read more →RMDResMed Elects Health Tech Leaders Desney Tan and John Hernandez to Its Board of Directors
Tan is vice president and managing director of Microsoft’s Health and Life Science R&D Hernandez is Google’s head of clinical research, health economics, and outcomes research Both leaders’ digital health experience at world-leading tech firms can help oversee ResMed’s strategy
Read more →RMDResMed Announces Participation in the Credit Suisse 30th Annual Healthcare Conference
SAN DIEGO, Nov. 03, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the Credit Suisse 30th Annual Healthcare Conference on Wednesday, November 10, 2021, beginning at approx
Read more →RMDResMed Inc. Announces Results for the First Quarter of Fiscal Year 2022
Year-over-year revenue grows 20%, operating profit up 21%, non-GAAP operating profit up 18% Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Oct. 28, 2021 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX
Read more →RMDFor investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2022 Year-over-year rev
For investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2022 Note: A webcast of ResMed s conference call will be available at 4:30 p.
Read more →RMDResMed to Report First Quarter Fiscal 2022 Earnings on October 28, 2021
SAN DIEGO, Oct. 07, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2022 on Thursday, October 28, 2021, after the New York Stock Exchange closes. Following the release
Read more →RMDResMed Announces Participation in the Morgan Stanley 19th Annual Global Healthcare Conference
SAN DIEGO, Sept. 02, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the Morgan Stanley 19th Annual Global Healthcare Conference on Thursday, September 9, 2021, beginning a
Read more →RMDResMed Announces SaaS Leadership Change
SAN DIEGO, Aug. 25, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD), today announced the promotion of Bobby Ghoshal to President of ResMed’s SaaS business, effective immediately. Raj Sodhi will be leaving full-time employment at ResMed, effective September 1. Bobby has ove
Read more →RMDResMed Launches AirSense 11 PAP Series, Advancing Digital Health in Sleep Apnea Treatment
SAN DIEGO, Aug. 16, 2021 (GLOBE NEWSWIRE) -- ResMed, a global leader in digital health and sleep apnea treatment, (NYSE: RMD, ASX: RMD) today launched AirSense 11, available first in the U.S., the company’s next-generation PAP (positive airway pressure) device designed to help hu
Read more →RMDResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2021
Year-over-year revenue grows 14%, operating profit up 8%, non-GAAP operating profit up 7% Quarterly dividend increases 8% to $0.42 per share Company to host a virtual Investor Day on September 8, 2021, at 1:30 p.m. PT Note: A webcast of ResMed’s conference call will be availab
Read more →RMDFor investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2021 Year-over-year re
For investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2021 Note: A webcast of ResMed s conference call will be available at 4:30 p
Read more →RMDResMed to Report Fourth Quarter Fiscal 2021 Earnings on August 5, 2021
SAN DIEGO, July 15, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2021 on Thursday, August 5, 2021, after the New York Stock Exchange closes. Following the release,
Read more →RMDResMed Announces Participation in the Goldman Sachs 42nd Annual Global Healthcare Conference
SAN DIEGO, June 02, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a virtual fireside chat at the Goldman Sachs 42nd Annual Global Healthcare Conference on Tuesday, June 8, 2021, beginn
Read more →RMDResMed Announces Participation in the William Blair 41st Annual Growth Stock Conference
SAN DIEGO, May 25, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a virtual fireside chat at the William Blair 41st Annual Growth Stock Conference on Tuesday, June 1, 2021, beginning at
Read more →RMDResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2021
- Year-over-year operating profit up 3%, non-GAAP operating profit up 2% Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, April 29, 2021 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX: RMD), a world-le
Read more →RMDFor investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2021 Year-over-year ope
For investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2021 Note: A webcast of ResMed s conference call will be available at 4:30 p.
Read more →RMDResMed Announces Participation in the 23rd Annual Macquarie Australia Conference
SAN DIEGO, April 27, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Brett Sandercock, chief financial officer, will present virtually at the Macquarie Australia Conference on Wednesday, May 5, 2021, beginning at approximately 8:45 a.m. (Australian Eastern S
Read more →RMDResMed to Report Third Quarter Fiscal 2021 Earnings on April 29, 2021
SAN DIEGO, April 08, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2021 on Thursday, April 29, 2021, after the New York Stock Exchange closes. Following the release,
Read more →RMDFor investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2021 Year-over-year re
For investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2021 Note: A webcast of ResMed s conference call will be available at 4:30 p
Read more →RMDFor investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2021 Year-over-year rev
For investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2021 Note: A webcast of ResMed s conference call will be available at 4:30 p.
Read more →RMDFor investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2020 Year-over-year re
For investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2020 Year-over-year revenue grows 9%, non-GAAP operating profit up Note: A
Read more →RMDFor investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2020 Year-over-year rev
For investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2020 Note: A webcast of ResMed s conference call will be available at 4:30 p
Read more →RMDFor investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2020 Year-over-year re
For investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2020 Note: A webcast of ResMed s conference call will be available at 4:30 p
Read more →RMDFor investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2020 Year-over-year rev
For investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2020 Note: A webcast of ResMed s conference call will be available at 4:30 p.
Read more →RMDFor investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2019 Year-over-year re
For investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2019 Note: A webcast of ResMed s conference call will be available a
Read more →RMDFor investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2019 Year-over-year rev
For investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2019 Note: A webcast of ResMed s conference call will be available at
Read more →RMDFor investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2019 Year-over-year gr
For investors For media Amy Wakeham Jayme Rubenstein +1 858-836-5000 +1 858-836-6798 investorrelations@resmed.com news@resmed.com ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2019 Note: A webcast of ResMed s conference call will be available at 4:30 p
Read more →RMDFor media: Jayme Rubenstein +1 858.836.6798 news@resmed.com For investors: Amy Wakeham +1 858.836.5000 investorrelations@resmed.com ResMed Completes Acquisition of MatrixCare - Establishes ResMed as a leader in out-of-ho
ResMed Completes Acquisition of MatrixCare SAN DIEGO November 14, 2018 ResMed (NYSE: RMD, ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-service (SaaS) business solutions, today announced it has completed its $750 million acquisition of
Read more →RMDFor media: For investors: Jayme Rubenstein Amy Wakeham +1 858.836.6798 +1 858.836.5000 news@resmed.com investorrelations@resmed.com ResMed to Acquire MatrixCare, Expands Out-of-Hospital SaaS Portfolio into Long-Term Care
For media: For investors: Jayme Rubenstein Amy Wakeham +1 858.836.6798 +1 858.836.5000 news@resmed.com investorrelations@resmed.com ResMed to Acquire MatrixCare, Expands Out-of-Hospital SaaS Portfolio into Long-Term Care Settings November 5, 2018 ResMed (NYSE: RMD, ASX: RM
Read more →RMDFor investors Amy Wakeham O: 858-836-5000 investorrelations@resmed.com For media Jayme Rubenstein O: 858-836-6798 news@resmed.com ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2019 ~ Strong year-over
ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2019 ~ Strong year-over-year growth in revenue, net income, and earnings per share ~ ~ Growth balanced across the entire product portfolio ~ Note: A webcast of ResMed s conference call will be available at 4:30
Read more →RMDFor investors Amy Wakeham O: 858-836-5000 investorrelations@resmed.com For media Jayme Rubenstein O: 858-836-6798 news@resmed.com ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2018 Revenue increased
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2018 SAN DIEGO, August 2, 2018 ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended June 30, 2018. Revenue for the quarter was $623.6 million, a 12 percent increase compared to the sa
Read more →Competitive Position
How RMD ranks across every disease it competes inCompetitive Position is a premium feature
See how RMD ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial